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Abstract 
 
The Endocrine Disrupter Screening Program of US EPA has recently developed a Tier 2 
testing guideline using model amphibian species Xenopus laevis.  The Larval Amphibian 
Growth and Development Assay assesses a chemical’s endocrine-related effects in vivo 
and generates concentration-response information for ecological risk-assessment.  
Currently, the assay relies on histopathological evaluations for identifying endocrine-
related reproductive effects.  However, histopathology can seldom define the chemical 
mode of action and is not easily interpreted in the context of risk assessment when the 
effects are minimal to moderate.  This study explores the use of gene expression 
biomarkers in the gonad that could potentially inform a chemical’s mode of action and 
detect adverse reproductive effects that are otherwise uncharacterized by histopathology.  
To identify candidate biomarkers, global expression was analyzed in differentiating ovary 
and testis tissues of Xenopus tropicalis.  Genetic programs responsible for reproductive 
maturation in gonad tissues were characterized and provided a foundation from which 
specific genes could be selected proximal to a model chemical’s known mode of action.  
Four genes were selected within the putative androgen molecular network to evaluate as 
biomarkers of the anti-androgen mode of action characteristic of a common fungicide, 
prochloraz.  Following continuous exposure to prochloraz throughout embryonic, larval 
and juvenile development in Xenopus laevis, assessments of growth, liver and kidney 
pathology, and reproductive development were made.  To evaluate the predictive 
capabilities of the candidate genes, one gonad was kept in situ for histopathological 
evaluations while the other was processed for mRNA analyses.  Results indicate that 
prochloraz exposure caused metabolic toxicity in the liver and kidney; it caused testis 
degeneration coincident with the onset of androgen-mediated spermatogenesis and 
inhibited regression of Müllerian ducts.  Two of the four candidate genes showed 
increases in expression at the high test concentration and appeared to be predictive of an 
anti-androgen-induced adaptive response.  The behavior of these biomarkers stimulated 
valuable discussion and generated testable hypotheses to better understand the evolution 
of molecular mechanisms driving gonad development in a cross-species context.  This 
study provides a model for expression-based biomarker development in endocrine tissues 
and offers direction toward enhanced ecological risk-assessment.             
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Overview 
 
Background 
The 1996 Food Quality Protection Act and an amendment to the Safe Drinking 
Water Act mandates the EPA to implement a screening program to determine whether 
certain substances interact with human endocrine systems causing adverse hormonal 
effects.  Following the passage of this legislation, EPA responded by chartering the 
Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) made up of 
representative scientists who recommended a tiered approach to endocrine disruptor 
testing that addresses effects in both humans and wildlife.  EDSTAC also recommended 
that screening and testing should include estrogen, androgen and thyroid-related 
processes.  The EPA’s Endocrine Disruptor Screening Program (EDSP) has been actively 
developing assays to identify endocrine disrupting chemicals (EDC) using a two-tiered 
approach.  Tier 1 screening assays are designed for high-throughput and to quickly 
identify whether a chemical will interact with some aspect of the endocrine system.  Tier 
2 testing systems are designed to assess Tier 1-active chemicals for endocrine-related 
effects in vivo and generate concentration-response information suitable for ecological 
risk assessment. 
As part of the Tier 2 assay design effort, a chronic toxicity testing procedure has 
been developed with amphibian species Xenopus laevis that considers growth and 
development from fertilization through the early juvenile period.  The Larval Amphibian 
Growth and Development Assay (LAGDA) involves a water-borne exposure of early life 
stage Xenopus laevis embryos with continuation of exposure until approximately two 
months following completion of metamorphosis, when the gonads are fully differentiated.  
Amphibian metamorphosis is a thyroid hormone-mediated process, so developmental 
assessments at metamorphic climax (Nieuwkoop and Faber stage 62) including growth, 
rate of somatic development, and thyroid gland histopathology allow the assay to identify 
potential thyroid-specific effects.  Continuation of the assay post-metamorphosis allows 
further evaluations of growth and reproductive development to help identify a 
substance’s potential to cause gonad dysgenesis or adverse effects on reproductive ducts.  
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Histopathological assessments of liver and kidney are also made at test termination as 
measures of overt toxicity. 
 
Problem         
 Tier 2 testing is designed to be a chronic toxicity testing paradigm.  This requires 
constant dosing of aquatic test chambers for up to six months while maintaining steady 
chemical concentrations and acceptable water quality.  The in-life portion of the LAGDA 
is resource-intensive in terms of man-hours for husbandry, water quality monitoring, 
mechanical maintenance of dilution systems, and weekly analytical chemistry.  
Subsequent to completion of a successful test, hundreds of fixed tissue samples are 
processed and evaluated for histopathology.  Needless to say, each attempt at this 
bioassay for a single chemical is extremely expensive and can take up to a year to acquire 
a completed study report. 
 As the LAGDA currently stands, histopathology evaluations are the most 
powerful and informative tool for assessing effects of chemical exposure on organs and 
tissues.  However, these types of assessments cannot inform the molecular mode of 
action of the chemical, nor are these assessments easily interpreted in the context of risk 
assessment when the effects present as minimal to moderate.  The research presented in 
this thesis explores the use of gene expression biomarkers as a supplement to LAGDA 
histopathology, specifically in the gonad, that could potentially inform the chemical 
mode of action and detect adverse reproductive effects in tissues presenting with minimal 
to no observable pathologies.  This work also provides a model for development of 
biomarkers in other tissues susceptible to perturbations due to xenobiotic exposure. 
 
Objectives 
 The objectives of this research are to (1) identify constitutive genes and genetic 
programs unique to each ovary and testis tissues during differentiation, (2) choose a 
subset of candidate genes to evaluate as biomarkers of gonadal dysgenesis mediated 
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through a particular mode of action, and (3) test candidate genes’ predictive capabilities 
using gonad tissues adversely affected by exposure to an endocrine disrupting chemical. 
 
Approach 
 Anuran sexual development and toxicology research has identified that many 
amphibian species are susceptible to chemical-induced gonad dysgenesis presenting as 
complete sex reversal or mixed sex gonads (Hayes, 1998; Kloas, 2002).  Exposure to 
exogenous estrogens generally cause either complete male-to-female sex reversal, or at 
lower doses, males will present with mixed sex gonad tissues exhibiting characteristics of 
both ovary and testis tissues (Bögi et al., 2002; Kloas et al., 1999; Pettersson et al., 2006; 
Villalpando and Merchant-Larios, 1990; Witschi and Allison, 1950).  Amphibian 
exposure to androgenic substances has presented mixed results differing by compound 
and species.  Xenopus laevis larvae exposed to testosterone did not change sex ratios, but 
dihydrotestosterone and methyltestosterone had similar masculinizing effects (Bögi et al., 
2002).  Xenopus tropicalis larval exposure to a synthetic androgen, 17β-trenbolone, 
caused significant masculinization and mixed sex gonad tissue at sub-lethal 
concentrations, but was unable to cause complete female-to-male sex reversal (Olmstead 
et al., 2012).  However, in Rana spp., androgen treatment produced 100% males 
(Kawamura and Yokota, 1959; Richards and Nace, 1978).  Complete female-to-male sex 
reversal was demonstrated in Xenopus tropicalis when the enzyme that converts 
androgen to estrogen (aromatase) was chemically inhibited, effectively diminishing 
intrinsic levels of estrogen (Olmstead et al., 2009a).  These modes of action occur 
through modulation of steroid hormone levels that translate to more or less activation of 
their respective cellular receptors (e.g. androgen receptor, estrogen receptor).  One 
alternative mode of action is antagonism of the androgen receptor itself, inhibiting proper 
signaling within target tissues.  Fungicides vinclozolin and prochloraz have been 
identified as anti-androgens causing altered sex differentiation (Gray et al., 1994) and 
impaired growth of androgen-dependent reproductive tissues (Vinggaard et al., 2002) in 
male rats respectively.  All of these modes of action are germane to a comprehensive 
understanding of molecular pathways leading to gonadal dysgenesis. 
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 As a first step toward understanding the molecular interactions associated with 
gonad dysgenesis in the context of amphibian Tier 2 testing, a thorough understanding of 
constitutive genetic programs in both testis and ovary tissues was needed - especially 
during the time at which the gonad is actively differentiating.  Knowing which genetic 
programs are unique to ovary and testis morphogenesis in Xenopus would provide a 
foundation from which specific hypotheses could be tested regarding targeted chemical-
induced perturbations.  To this end, global gene expression analysis was performed on 
ovary and testis tissues during gonad differentiation in Xenopus tropicalis.  This species 
was used (as opposed to Xenopus laevis) because its genome was sequenced and fully 
represented on a commercially available microarray chip.  Details regarding this 
descriptive study are presented as Chapter 1. 
 Following the gene array study, potential biomarkers of gonadal dysgenesis were 
evaluated in conjunction with development of the EDSP amphibian Tier 2 bioassay.  An 
anti-androgenic imidazole fungicide, prochloraz, was one chemical to be tested in the 
validation effort of the Tier 2 test guideline.  Based on the anti-androgenic mode of action 
of prochloraz, four genes were chosen to evaluate as potential biomarkers of testis 
dysgenesis.  These genes were chosen based on several criteria: (1) according to the gene 
array study, they had to exhibit robust expression profiles that were statistically testis-
biased, (2) they had to be well-annotated and well-characterized in gonadal development 
within and between species, and (3) they had to have high likelihood of informing the 
chemical mode of action.  Of the candidate genes that met these criteria, four were 
chosen to be evaluated as potential biomarkers using quantitative PCR.  Details regarding 
the prochloraz exposure and results are presented as Chapter 2. 
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Chapter 1: Global gene expression analysis during early 
differentiation of Xenopus (Silurana) tropicalis gonad tissues. 
 
1. Introduction 
African clawed frog Xenopus sp. has been used extensively for developmental 
biology and toxicology research.  With mounting concerns about wildlife exposure to 
environmental pollutants and potential endocrine disrupting compounds (reviewed by 
Kloas, 2002), efforts to better understand the mechanisms by which xenobiotics cause 
reproductive harm are warranted.  Many studies have demonstrated the susceptibility of 
amphibians to altered gonadal development due to xenobiotic or exogenous hormone 
exposure resulting in sex reversal or altered sex ratios (Bögi et al., 2002; Olmstead et al., 
2009a; Othani et al., 2000; Pettersson et al., 2006; Reeder et al., 1998; Villalpando and 
Merchant-Larios, 1990).  The molecular processes of sex determination in amphibians 
vary by species, but many of the downstream molecular processes driving differentiation 
(e.g., steroid hormones) are similar even across taxa (reviewed by Hayes, 1998).  With 
the latest technological advances in global gene expression analysis, it may be possible to 
characterize the genetic programs responsible for gonad differentiation so similarities and 
differences can be identified between species.  These similarities and differences could 
then be exploited in biological and toxicological research to enable better cross-species 
extrapolations following targeted experimentation involving genetic manipulations. 
  Three events are operative sequentially in determining the sex of most 
vertebrates: fusing of the gametes at conception (e.g., XX/XY or ZZ/ZW sex 
chromosomes), sex determination by a molecular switch during embryonic or larval 
development, and finally, the cascading molecular expression patterns set in motion by 
the sex determination switch.  Prior to sex determination in Anurans, the undifferentiated, 
bipotential gonad consists of a cortex and medulla (Merchant-Larios and Villalpando, 
1981).  In Xenopus tropicalis, the first signs of testicular differentiation at the histological 
level occur around Nieukoop and Faber ([NF] 1994) stage 48, while the first evidence of 
ovarian differentiation occurs around NF stage 51 based on differences in laminin 
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localization patterns (El Jamil et al., 2008).  The primordial germ cells (PGC) reside in 
the cortex of the bipotential gonad and continue to remain in the cortex of the female 
gonad while the medulla recedes to an inner epithelial layer forming a lumen (Ogielska, 
2009a).  In the testis, the PGCs migrate from the cortex to the medulla; the cortex 
eventually disappears in lieu of the peritoneal epithelium.  These processes are initiated 
and orchestrated by genetic control, but the exact mechanisms have not been elucidated 
in Anuran species (Hayes, 1998).  By NF58, the gonad is fully distinguishable 
histologically as either an ovary or a testis based on the presence or absence of the cortex 
and medulla (Figure 1.1). 
 
 
Figure 1.1. Histological sections of ovary and testis tissues at NF58, NF66, and two weeks post-
metamorphosis (2WPM).  Stained with H&E.  O: ovary; T: testis; C: cortex; M: medulla; L: lumen. 
 
Following NF58, many noticeable changes take place histologically that indicate 
substantial up-regulation of differentiation processes.  In the ovary, primary oogonia are 
actively dividing mitotically and form germ cell nests of secondary oogonia (Ogielska, 
2009b).  These germ cell nests are surrounded by somatic pre-follicular cells that will 
eventually support development of the diplotene oocytes.  Blood vessels and 
mesenchyme cells migrate into the cortex through the thin space between the cortex and 
what was previously the medulla.  These blood vessels will eventually deliver yolk 
T-2WPM
O-NF66 O-2WPM
T-NF66
O-NF58
T-NF58
C
M
L
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precursors to the oocytes from the liver where they are synthesized.  Secondary oogonia 
become primary oocytes and proceed through meiosis to the diplotene stage, when 
follicular cells proliferate and envelop each oocyte to form follicles.  Within each follicle, 
oocytes begin to protrude microvilli that interlace with follicular cell macrovilli, and gap 
junctions are formed between the oocyte and follicular cell villi which allow more 
surface area for passage of hormones and signaling molecules between cells to direct 
oocyte meiosis and maturation.  The microvilli of the oocyte begin to branch out at their 
tips, running parallel with the oocyte surface creating an envelope (zona pellucida) where 
glycoproteins are localized to mediate the acrosome reaction and resist polyspermy.  An 
extensive network of cytoskeletal components are assembled in the diplotene oocyte to 
traffic molecules and prepare for resumption of meiosis when triggered by progesterone 
much later in development.  By two weeks following the completion of metamorphosis, 
the ovary contains pre-meiotic germ cells and meiocytes representing every stage of 
meiosis up to the arrested diplotene stage.   
The histological hallmarks of testis differentiation throughout this period of 
development are mainly cellular organization and proliferation, as spermatogenesis does 
not commence until seminiferous tubules are fully developed closer to sexual maturity.  
However, notable activities include invasion of blood vessels and mesenchyme cells into 
the testis between the cortex and medulla (as in the ovary), primary spermatocytes 
become encapsulated by somatic cells and organize into primordial seminiferous cords 
that eventually become tubules, and mesenchyme cells differentiate into Leydig cells that 
will produce steroid hormones (Ogielska, 2009c).  Overall, the ovary undergoes more 
activity in germ cell development while the testis experiences more cellular movement 
and organization for duct formation. 
The objective of this study was to characterize gene expression patterns 
associated with Xenopus tropicalis gonad differentiation and to identify candidate genes 
having robust associations with gonad development.  A secondary objective was to 
compare the candidate gene expression profiles to existing knowledge of the orthologous 
gene expression in other species during gonadal development, to broaden the 
understanding of functional significance in a cross-species context.  To that end, temporal 
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global expression profiles were measured in four different stages of differentiating 
Xenopus tropicalis ovary and testis tissues by microarray.  Resulting expression profiles 
were compared between tissues at each developmental stage and enriched gene sets were 
analyzed further for functional associations.  As part of the analysis process, human 
orthologs were identified for as many probe sets as possible so the extensive mammalian 
molecular interaction databases could be used for functional analyses and cross-species 
comparisons.    
 
2. Materials and methods 
2.1 Animal care and culture 
 
The in-house X. tropicalis breeders used to generate animals for this study were of 
the “golden strain” and the female was confirmed to have the W-linked polymorphism 
identified by Olmstead et al. (2010).  This sex-linked marker and a housekeeping marker 
were used to determine genetic sex of the offspring following sampling (described later).  
The animal care and culture conditions were the same as described by Olmstead et al. 
(2009b) and were as follows.  Adult breeding pairs were maintained on a 12:12 light:dark 
photoperiod at 25oC in 7 L glass aquaria with 50ml/min flow-through conditions and 
were fed 3/32′′ premium sinking frog food pellets (Xenopus Express, Plant City, FL, 
USA).  Water was from nearby Lake Superior (Duluth, MN, USA) and was ozone treated 
and filtered prior to use.  Mating of breeding pairs was induced by injections of human 
chorionic gonadotropin (Sigma Aldrich, St. Louis, MO, USA).  An initial injection of 
20 IU gonadotropin followed by a second injection of 100 IU gonadotropin 5 hours later 
were administered to both the male and female breeder.  Following mating, the adult 
breeders were moved to another tank and embryos were allowed to hatch in flow-through 
conditions.  A single spawn was disbanded to a density of 40/tank (12:12 photoperiod, 
25oC, 7L tank, 25ml/min flow) and fed a diet consisting of homogenized cooked carrot 
and spinach, Sera Micron (Sera North America, Toronto, Canada), and brine shrimp three 
times daily until removed for sampling. 
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2.2 Experimental design 
 
 Four developmental time-points were considered for global expression analysis: 
NF58 (pro-metamorphosis), NF66 (completion of metamorphosis), one week post-
metamorphosis (1WPM), and two weeks post-metamorphosis (2WPM).  Gonad tissues 
were time-matched and stage-matched, so collection occurred on a single day for each 
developmental time-point and all animals used were from the same spawn.  For the 
1WPM and 2WPM time-points, all animals reached NF66 on the same day and were 
separated from the rest of the spawn until sample collection one and two weeks later 
respectively.  On the day of tissue collection, animals were developmentally staged 
(Nieuwkoop and Faber, 1994) and euthanized by submersion in a lethal concentration of 
tricane methanesulfonate ([MS-222], Argent Chemical Laboratories, Redmond, WA, 
USA) buffered with sodium bicarbonate. Gonad tissues were then excised and transferred 
to a separate vial for each individual, homogenized in lysis buffer from an RNeasy micro 
kit (Qiagen Inc., Valencia, CA, USA), and immediately frozen on dry ice until samples 
could be moved to -80oC storage.  Tail or toe tissue was also collected from each 
individual for genetic sex determination using methods previously described by Olmstead 
et al. (2010).  Once genetic sex was determined for each individual, testes and ovaries 
were randomly assigned to pools of four individuals (eight gonads per pool) to make a 
total of five pools of testis tissue and five pools of ovary tissue at each developmental 
time-point, with the exception of NF58 which had four pools of testis tissue and four 
pools of ovary tissue.         
2.3 Total RNA target preparation and hybridization 
 
Homogenates corresponding to the four individuals to be pooled were combined 
and then total RNA was extracted from each pool according to RNeasy kit instructions 
(Qiagen Inc., Valencia, CA, USA).  RNA concentrations were measured on a NanoDrop 
ND-1000 Spectrophotometer (NanoDrop Technologies, Inc., http://www.nanodrop.com) 
and quality was checked using a 2100 Bioanalyzer with an RNA 6000 pico assay 
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(Agilent, Santa Clara, CA, USA).  Samples were then frozen at -80oC and shipped to the 
US EPA Genomics Research Core in Research Triangle Park, NC, where each RNA pool 
was amplified and labeled using the 3’ IVT Express kit (Affymetrix, Santa Clara, CA, 
USA) according to kit instructions.  Subsequent hybridization, washes, staining, and 
array scanning were performed according to Affymetrix GeneChip® Xenopus tropicalis 
Genome Array Expression Analysis instructions.  CEL files containing feature intensities 
were generated using Affymetrix GeneChip® Command Console® software. 
2.4 Data analysis   
2.4.1 Data summarization 
The data files (CEL) were imported into GeneSpring GX 12.6 (Agilent) software 
where they were summarized using the PLIER16 algorithm including a baseline 
adjustment to the median of all samples.  The PLIER16 algorithm assumes multiple-array 
analysis, uses quantile normalization and a weighted approach to background correction 
using perfect match and mismatch probe pairs (Hubbell, 2004, 2005).  Quality control 
was performed on all arrays using principle component analysis and hybridization control 
comparisons.  The series of biotin-labeled hybridization control levels for one sample 
replicate (NF58 testis) were indicative of faulty hybridization.  This sample was 
determined to be compromised based on these hybridization controls and was removed 
from subsequent analyses.  As a result, the NF58 testis sample set consisted of three 
replicates while there were four replicate NF58 ovary samples. 
2.4.2 Enhanced annotation 
In order to utilize Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, 
Inc., Redwood City, CA, USA) developed for mammalian gene network, pathway and 
functional analysis, putative human orthologs were identified for as many probe sets as 
possible.  This was performed by using Python programming language (version 2.7) to 
search the UniGene database (National Center for Biotechnology Information, 
http://www.ncbi.nlm.nih.gov/unigene) with each UniGene ID provided in the Xenopus 
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tropicalis GeneChip® annotation file.  If a human alignment was present for a particular 
X. tropicalis UniGene ID, the human protein accession number was appended to the 
annotation file for the associated probe set ID.  Some probe sets had multiple associated 
UniGene clusters and therefore had multiple UniGene IDs.  For cases where multiple 
human orthologs were found for a single probe set, the human ortholog with the highest 
alignment score was used for any subsequent analyses.  The Python code written for this 
procedure is provided as Appendix A.  For details on UniGene cluster assignments and 
protein similarity criterion, see UniGene FAQ 
(http://www.ncbi.nlm.nih.gov/UniGene/help.cgi?item=FAQ).  The updated annotation 
file was then imported into GeneSpring so post-analysis gene lists including human 
ortholog accession numbers for IPA recognition could be exported. 
2.4.3 Differential expression analysis and clustering 
T-tests assuming unequal variance (Welch) were performed to compare the testis 
versus ovary tissues at each of the developmental stages (Table 1.1). P-values were 
computed asymptotically and the Benjamini Hochberg FDR multiple testing correction 
was applied (corrected p-value cutoff = 0.01).  This analysis generated a gene list for 
each developmental stage which exhibited ≥ 2-fold, ≥ 5-fold, and ≥ 10-fold differential 
expression between tissues.  The 2WPM, ≥ 5-fold gene list was chosen for functional 
analyses due to the 2WPM gonadal tissues being most differentiated and exhibiting the 
most differentially expressed transcripts.  Additionally, using the ≥ 5-fold cutoff as 
opposed to the ≥ 2-fold cutoff was meant to target transcripts with more robust 
differences, but to also remain more inclusive than the ≥10-fold cutoff.  Hierarchical 
clustering was performed on the 2WPM, ≥ 5-fold transcript list using Euclidian similarity 
measure and Ward’s linkage rule.  Similarity was determined using the transcript profile 
across all eight conditions (each gender and developmental stage) (Figure 1.2). 
2.4.4 Functional analyses 
 Five clades from the hierarchical dendogram were chosen for functional analyses 
based on the similarity of their expression profiles.  The testis-enriched transcripts 
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represented two clades while the ovary-enriched transcripts represented three clades.  
These five clades were exported from GeneSpring as individual gene lists including 
human orthologs and were then imported into IPA separately for functional analyses.  
Transcripts not having a human ortholog were filtered out during the import by default.  
Also, not all of the recognized ortholog accessions were considered for analyses because 
interaction data is not yet available for every molecule in the IPA database.  Therefore, 
the resulting number of molecules considered in each analysis was always less than the 
number of transcripts in the original lists.  
 
3. Results 
Xenopus tropicalis ovary and testis transcriptomes were analyzed at four different 
developmental stages during active tissue differentiation using Affymetrix GeneChip 
technology.  Each of the arrays contained 59,021 probes representing approximately 
51,000 transcripts.  The objective of this study was not only to identify transcripts 
differentially expressed between the two tissue types, but to identify transcripts showing 
robust differences between the tissues attributable to the genetic programs associated 
with gonad differentiation processes.  Therefore, stringent cutoffs were applied including 
a corrected p-value cutoff of 0.01 (Benjamini Hochberg FDR) and fold difference cutoff 
of ≥ 5-fold for functional analyses.   
3.1 Differential expression and clustering 
 
According to the corrected p-value cutoff of 0.01, there were very few 
differentially expressed transcripts between tissue types at NF58 and all were testis-
enriched (i.e., elevated expression levels in the NF58 testis as compared to the NF58 
ovary) (Table 1.1).  Between NF58 and the completion of metamorphosis (NF66), there 
was an appreciable increase in the number of differentially expressed transcripts, with 
subsequent increases throughout the remaining developmental stages.  In most cases, 
aside from NF58, the testis-enriched transcripts make up approximately 1/3 of the total 
differentially expressed transcripts regardless of fold-differences.  
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Table 1.1. Numbers of transcripts differentially expressed between tissues at each developmental stage. (T-test 
assuming unequal variance; Benjamini Hochberg FDR corrected p < 0.01). 
Format of each cell: Testis-enriched / Ovary-enriched 
Fold difference 
Dev. Stage ≥2-fold ≥5-fold ≥10-fold 
NF58 7 / 0 7 / 0 7 / 0 
NF66 588 / 1079 88 / 91 27 / 19 
1WPM 692 / 1626 95 / 196 41 / 54 
2WPM 1487 / 2617 143 / 292 53 / 111 
 
As explained in methods section 2.4.3, a decision had to be made regarding which 
transcript list to carry forward for functional analysis in order to set limits on the scope of 
the analysis.  Gonad tissues at 2WPM are most differentiated histologically as compared 
to the earlier developmental stages and the differential expression data in Table 1.1 
corroborates this fact.  With regard to the fold-change cutoff, use of transcripts ≥ 5-fold 
different between tissues was intended to include only those transcripts showing robust 
differences between tissues, but at the same time, remain more inclusive than the ≥ 10-
fold cutoff.  Therefore, clustering and functional analyses were performed on the 2WPM, 
≥ 5-fold differentially expressed transcript list.   
Hierarchical clustering revealed a distinct separation between ovary and testis 
expression profiles (Figure 1.2).  For interpretation, a coarse threshold was set to divide 
the dendogram into five clusters, which were each later analyzed for function using IPA 
software.  Generally, testis-enriched transcripts in both clades are already being 
expressed at NF58 and continue to be highly expressed throughout the developmental 
periods examined.  Transcript profiles in the ovary, particularly clade A, indicate that 
expression is initiated for many genes starting between NF58 and NF66 and levels of 
expression increase throughout this period of development, whereas many other ovary-
enriched genes, most notably clade C, are induced sometime between one and two weeks 
post-metamorphosis.   
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3.2 Functional analyses 
3.2.1 Ovary Clade A 
 Transcript expression profiles in this 
cluster are increasing substantially in the 
ovary throughout this period of development 
starting sometime between NF58 and NF66 
(Figure 1.2, Appendix B).  Each of the three 
ovary clusters show different timing of 
general transcript up-regulation.  Ovary A 
generally shows up-regulation following 
Ovary B and prior to Ovary C.   Many 
transcripts in the Ovary A cluster are 
functionally associated with gonadogenesis, 
gametogenesis, meiosis, and fertility 
including FIGLA, BRDT, TDRD5, PABPC1L, 
HORMAD1, TEX11, and MSH5.  
Interestingly, BRDT, TDRD5, HORMAD1 and 
TEX11 are associated with testis development 
in mammals and are being highly expressed in 
differentiating ovary tissue of Xenopus 
tropicalis.  Several other transcripts are 
functionally associated with ovary 
development and oocyte maturation (LHX8, 
NPM2, GTSF1, CGA, ZGLP1).  Additionally, 
many transcripts are associated with DNA 
replication, recombination, and repair, of 
which some are also associated with cell 
cycle and meiosis of germ cells (DMC1, HORMAD1, MSH5, BRDT, TEX11, NPM2, 
TBP, SASS6, BANF1, SYCE2).  Another interesting result from this cluster is that many 
Figure 1.2.  Hierarchical clustering of the 
2WPM, ≥ 5-fold transcript list using 
Euclidian similarity measure and Ward’s 
linkage rule.  On the heatmap, red indicates 
the highest normalized expression level, 
green indicates the lowest normalized 
expression level and black indicates 
expression levels close to the median of all 
samples.  Cluster designations are listed 
down the right side and correspond to 
specific clades within the dendogram on 
the left side of the heatmap. 
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transcripts are functionally associated with cancer, but lack information about more 
specific functions (see Appendix B).  This is likely an artifact of the context in which 
these genes have been studied and the metadata associated with them in the IPA database.  
Nonetheless, these genes are likely associated with cell proliferation.  The majority of 
gene products in this cluster reside in the nucleus (40%) and cytoplasm (32%) indicating 
an emphasis on intracellular processes (Figure 1.3). 
 
 
 
 
Figure 1.3.  Cellular distributions of gene products by cluster.  Total numbers of unique gene products per 
cluster are in parentheses next to cluster ID.  Cellular location information was derived from IPA output. 
 
3.2.2 Ovary Clade B 
 This cluster shows the earliest differential expression of the three ovary clusters 
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development (Figure 1.2, Appendix B).  Transcripts in this cluster are mainly associated 
with gonad morphology (CHST8, EMX2, CYP26A1, GGT1, IRX5), cell proliferation 
(OLFML2A, LUM, NPPC, ESRP1, CLDN6, CLDN7, TACSTD2) and primary sex 
determination (EMX2, CYP19A1).  Several transcripts are also associated with nervous 
system development (NTN1, KAL1, IRX5, A2M, IRX3).  Interestingly, several of the 
upstream regulators predicted to be controlling expression in this cluster are being 
expressed in testis tissue throughout this period of development (Testis Clade A: FGF10, 
RARRES1, DAX-1).  Other predicted upstream regulators of genes in this cluster include 
β-estradiol, progesterone, and FSHβ.  Gene products in this cluster primarily reside in the 
extracellular space (29%) and plasma membrane (24%) indicating an emphasis on 
intercellular signaling/activity (Figure 1.3).  
3.2.3 Ovary Clade C 
 Transcripts in this cluster are substantially up-regulated between 1WPM and 
2WPM.  Many of them have very similar temporal expression profiles and similar 
magnitudes of up-regulation at 2WPM.  Functionally, these genes are associated with 
reproductive system development and gametogenesis (BMP15, CCNA1, COMT, GJA4, 
H2AFX, NANOS2, OCA2, SOX2, ZP3), cell cycle and meiosis (BMP15, BTG3, BTG4, 
CCNA1, CCNB1, EIF4E, LGALS3, MAD1L1, SOX2, WEE2), transcription (BMP15, 
BTG3, CAPRIN2, FOXH1, GSTP1, GTF3A, H2AFX, MAD1L1, SALL4, SOX2, TDGF1, 
ZFP36, ZFP36L2, ZIC2, ZP3), and RNA binding, stabilization and trafficking (CCNB1, 
EIF4E, ZFP36, ZFP36L2).  Possible upstream regulators of genes in this cluster are 
NOBOX, MYBL2, SALL4 and FIGLA.  FIGLA is present in the Ovary A cluster and 
shows a substantial increase in expression starting between NF66 and 1WPM, which 
precedes up-regulation of many genes in this cluster making it a particularly strong 
candidate transcriptional regulator.  Gene products in this cluster mainly reside in the 
cytoplasm (37%) and nucleus (22%) indicating an emphasis on intracellular processes 
and is consistent with cell cycle regulation, transcription, and RNA binding, stabilization, 
and trafficking occurring for developing meiotic oocytes (Figure 1.3). 
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3.2.4 Testis Clade A 
 Gene expression profiles in this cluster generally show less differential expression 
between tissue types overall as compared to the Testis B cluster (Appendix B).  
Additionally, most of the transcripts in this cluster become more testis-biased between 
NF66 and 2WPM.  This is due in part to general decreases in ovary transcript expression 
while testis expression remains constant (upper half of cluster) and general increases in 
testis transcript expression while ovary expression remains constant (lower half of 
cluster) (Figure 1.2).  Many transcripts in this cluster are involved in cardiovascular 
system development (TPM2, GAS6, CNN1, FBLN5, KCNJ8, MYH11), vasculogenesis 
(FHL2, COL13A1, ENPP2, SEMA3B, COL8A1, TGM2), and connective tissue 
development (INHA, INHBA, DHH, NLK, COL9A1, FHL2, FGF10) (Appendix B).  
There are also many transcripts involved in reproductive system development and testis 
morphology (NKX3-1, SRD5A2, INHA, INHBA, DHH, CYP26B1, FGF10, DAX-1, 
SNAI2).  Some of the same genes associated with testis morphology are also associated 
with sex determination (SRD5A2, INHA, DHH, DAX-1).  In addition, there was 
significant enrichment of transcripts associated with steroidogenesis and androgen 
biosynthesis in this cluster (AKR1C3, CYP17A1, SRD5A2, DKK3, INHBA, KITLG).  
Upstream regulation analysis identified TGFβ and androgen receptor as potential 
activators based on enrichment of transcripts involved in those pathways.  Gene products 
in this cluster show fairly even representation of possible cellular locations with a slight 
majority occurring in the cytoplasm (31%) (Figure 1.3).       
3.2.5 Testis Clade B 
 Gene expression profiles in this cluster exhibit substantial expression levels in the 
testis throughout this period of development and are markedly higher than ovary 
expression levels, which are ostensibly absent (Figure 1.2, Appendix B).  Functional 
analysis of this cluster indicates significant contributions to cardiovascular, connective 
tissue, and nervous system development as in the Testis A cluster.  Specifically, 
transcripts are associated with blood vessel development (ACTA2, MYL4, AQP1, 
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FGFBP3), angiogenesis (AQP1, GPC1, NPTX1), collagen development (BMP1), and cell 
signaling and nervous system development (NPTX1, SLITRK4, HTR2C, CLEC4M).  
Three transcripts in this cluster are functionally associated with reproductive system 
development (INSL3, ASTL, AQP1) with the first two being associated with fertility.  
Functional analysis of this cluster also identified laminin as a potential upstream 
regulator.  Laminin is localized to the basal membrane surrounding seminiferous tubules 
in Xenopus tropicalis testis tissue (El Jamil et al., 2008) and is known to influence cell 
migration, differentiation, and tissue organization (Hadley et al., 1990; Sasaki et al., 
2004).  The majority of gene products in this cluster are located in the extracellular space 
(33%) and plasma membrane (27%) indicating an emphasis on intercellular signaling and 
tissue development.   
 
4. Discussion 
 
Gonad tissues are unique from other vertebrate tissues in that the indifferent 
gonad is triggered, through genetic programs, to differentiate into two morphologically 
distinct mature tissues that both support germ cells and ultimately support reproduction.  
Gonad phenotype is determined genetically in some vertebrate species and by 
environmental triggers in others (e.g., temperature).  However, the sequence of events 
following sex determination and the molecular factors responsible for developing these 
tissues are similarly orchestrated in gonads across many vertebrate species, all in support 
of germ cells.  Since gonad differentiation is susceptible to chemical perturbations 
leading to infertility or sex reversal at the individual level, efforts are necessary to 
understand the vulnerable targets and pathways leading to aberrant gonad development 
potentially causing adverse effects at the population level.   
To contribute to the knowledge base at the molecular level, we employed 
microarray technology to identify gender differences in the genetic programs associated 
with gonadal development and differentiation in model Anuran species Xenopus 
tropicalis.  To date, global gene expression analysis has not been performed strictly on 
ovary and testis tissues this early in Xenopus development, as they are difficult to excise 
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and close to impossible to differentiate visually.  Recent advances in Xenopus research 
allows for the genetic determination of gender in individual animals (Olmstead et al., 
2010; Yoshimoto et al., 2008) making it possible to extract ovary and testis tissues from 
larvae prior to these tissues becoming visibly dimorphic.  By collecting tissues at four 
different time-points through development, temporal profiles of gonad gene expression 
specific to each sex were acquired.      
Differentially expressed transcripts were clustered by their temporal profiles, and 
bioinformatic analyses of gene function and pathway enrichment were performed to 
associate transcripts with tissue processes and to identify potential upstream regulators.  
Performing these types of analyses with molecular interaction, pathway, and functional 
annotations specific to Xenopus proved to be both bioinformatically cumbersome and not 
easily interpreted.  In contrast, the mammalian-based Ingenuity Pathway Analysis 
software provided a reasonably comprehensive analysis that facilitated more meaningful 
interpretation of results.  However, human orthologues had to be acquired from the NCBI 
UniGene database in an automated fashion using Python scripting language.  The 
assumption underlying the analysis is that orthologous genes play similar roles in frogs 
and humans. While it is recognized that there may be exceptions, the expression profiles 
of well-characterized gender-biased genes in gonad tissue including CYP19A1 and 
SRD5A2 provided confidence that this assumption was generally valid. 
4.1 Ovary 
 
 At larval somatic stage NF58, the ovary (stage IV according to Ogielska and 
Kotusz’ 2004 staging criteria for Anuran ovary development) exhibits a cortex containing 
germ cells and germ cell nests separated by a layer of prefollicular cells.  At this stage of 
ovarian differentiation, the germ cells are dividing mitotically while blood vessels and 
mesenchyme cells invade the cortex (Ogielska, 2009b).  The suite of genes being 
expressed at this time are in Ovary Clade B which includes, most notably, those coding 
for enzymes CYP19A1 (aromatase) and CYP26A1.  Aromatase catalyzes the production 
of 17β-estradiol, which has been studied extensively for its role in sex determination and 
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sexual differentiation.  It is no surprise aromatase is being expressed in the ovary as it is 
widely accepted to be a determining factor for whether the bipotential gonad becomes a 
testis or ovary; its expression profile supports the quality of these results.  CYP26A1 is 
primarily involved in retinoic acid regulation and has been shown to be estrogen-
responsive in human endometrium (Deng et al., 2003).  Retinoic acid has also been 
identified as the key factor for initiating sex-specific timing of germ cell entry into 
meiosis in mammals (reviewed by Bowles and Koopman, 2007).  Based on the timing of 
expression of other meiosis-specific transcripts in this dataset, it is highly plausible that 
retinoic acid, and regulator CYP26A1, are responsible for initiating X. tropicalis oocyte 
meiosis in a similar fashion. 
 Oocyte meiosis begins during ovary stage V which is approximately concomitant 
with the completion of metamorphosis (NF66).  Many transcripts in Ovary Clade A are 
associated with meiosis and are up-regulated around NF66 including HORMAD1, 
SPDYA, MSH5, SYCE1, BRDT, TEX11, DMC1, TDRD5, and others.  Interestingly, 
HORMAD1, BRDT, TEX11, and TDRD5 have been primarily associated with testis tissue 
in mammals and were found to be playing roles in male germ cell meiosis (Chen et al., 
2005; Gaucher et al., 2012; Jones et al., 1997; Wang, P.J. et al., 2001; Yabuta et al., 
2011), but it is suggestive here that these genes also play significant roles in X. tropicalis 
oocyte meiosis.  This superficial inconsistency in functional analysis output is another 
example of an artifact of the context in which genes have been studied and the metadata 
associated with them in the functional database.  Upon further investigation, HORMAD1, 
BRDT, and TEX11 have been found to play roles in both spermatocyte and oocyte 
meiosis (Houmard et al., 2009; Kogo et al., 2012; Paillisson et al., 2007).  In mouse 
spermatogonial cell lines TEX11 has been shown to modulate effects of estrogen 
receptor-β, and overexpression resulted in enhanced transcription of an estrogen-
responsive reporter gene (Yu et al., 2012).  Given the importance of estrogenic influence 
on gonadal development, TEX11 could be a critical factor in Xenopus ovary and germ 
cell development ultimately affecting fertility.   
 Prior to the appearance of diplotene oocytes, which occurs during ovary stage VI, 
transcripts coding for notable transcription factors including TBP, LHX8, and FIGLA are 
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ovary-enriched.  During this time, early folliculogenesis takes place and is orchestrated 
by signaling between the oocyte and cumulous, or granulosa cells.  FIGLA has been 
shown to directly regulate transcription of a series of glycoproteins localized to the 
oocyte zona pellucida (Soyal et al., 2000).  Notably, ZP3 and ZP4 are up-regulated 
subsequent to the up-regulation of FIGLA in this dataset.  In mouse oocytes FIGLA 
appears to repress expression of testis-associated genes including CYP17A1, DKKL1, 
TDRD1, TDRD6, TDRD7, and others, while activating factors associated with oocyte 
development (Hu et al., 2010).  Expression profiles of CYP17A1 and DKKL1 isoform 
DKK3 in the present dataset are consistent with the findings of Hu et al. (2010) whereas 
the tudor-domain isoform TDRD5 expression profile is ovary-enriched.  This difference 
could be species related, temporally related, or isoform related, all of which would 
require further investigation.  However, FIGLA has been well-characterized in 
mammalian reproductive development and plays a critical role in ovary development and 
fertility.  These data support the structural and functional conservation of this 
transcription factor and its importance to ovary development across species. 
 Transcription factor LHX8 has also been implicated in mammalian ovary 
development and fertility (Choi et al., 2008).  Deficiencies in LHX8 cause misexpression 
of GDF9, POU5F1, NOBOX, KIT, and KITL.  NOBOX and paralog POU4F1 were both 
predicted upstream regulators of ovary-enriched genes in clades B and C.  NOBOX has 
been shown to regulate germ-cell specific genes such as BMP15 and ZAR1 (Rajkovic et 
al., 2004), both of which are highly ovary-enriched here at 2WPM.  BMP15 and GDF9 
are close homologs in the TGF-β superfamily of growth factors and are both responsible 
for activation of primordial follicle development in the human ovary in vitro (Kedem et 
al., 2011).  Although GDF9 was not represented in Appendix B, it was ovary-enriched at 
2WPM by over 2-fold (corrected p <0.01) supporting its role in follicle development 
across species.  In X. tropicalis, KITL message is continually increasing in testis tissue 
over this period of development.  While in the ovary, expression of this transcript 
continually decreases.  This appears inconsistent with what is reported in mammalian 
primordial follicle development (Driancourt et al., 2000), as KIT (receptor) together with 
KITL (ligand) control oocyte growth and theca cell differentiation, and protects preantral 
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follicles from apoptosis.   However, KITL has been well-characterized as an essential 
factor for mammalian spermatogenesis and male fertility (Vincent et al., 1998) consistent 
with expression levels in X. tropicalis testis tissues here.  Furthermore, this emphasizes 
the potential importance of its proper expression and uninhibited function for 
reproductive success in mammals and amphibians alike.     
In addition to transcription factor signaling during early folliculogenesis, maternal 
mRNAs begin to be transcribed in maternal cells and are localized to the developing 
germ cells.  In Xenopus laevis embryos, maternal stores of TBP mRNA become 
translated leading up to the mid-blastula transition of embryogenesis and are 
translationally masked by association with a repressive protein prior to this event 
(Veenstra et al., 1999).  This increase in TBP protein coincides with an increase in RNA 
polymerase I protein to which TBP associates in order for active translation to take place 
during embryogenesis (Bell and Scheer, 1999).  TBP appears to be one of many maternal 
mRNAs that begin to be localized to the soon diplotene oocytes.  However, TBP 
expression is up-regulated here around NF66, which is well before many of the other 
maternal mRNAs are up-regulated indicating a possible role in translation both in 
primordial follicle development and embryogenesis. 
  During ovary stage VI and around 2WPM, oocytes reach the diplotene stage of 
meiosis, and oocyte maturation processes begin including maternal RNA transport and 
localization within the oocyte, arrangement of the cytoskeleton and microvilli in the 
oocyte cortex, and incorporation of sperm receptor glycoproteins in the zona pellucida 
(Ogielska, 2009b).  Components of these processes are evident in this data set, especially 
in Ovary Clade C, as most of these gene profiles show substantial expression levels 
starting at the 2WPM time-point.  Notable maternal mRNAs in this dataset previously 
identified as oocyte-specific are ZAR1, NANOS1, FOXI2, H1FOO, and VEGT to name a 
few that play key roles in embryogenesis following fertilization (Cha et al., 2012; Furuya 
et al., 2007; Lai et al., 2012; Wu et al., 2003).  Translational control of mRNAs is evident 
by several regulators that are highly ovary-enriched here (ZFP36, ZFP36L2, EIF4E, 
PABPCL1).  These may play roles in maternal mRNA translational regulation and/or 
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regulate translation of factors involved in follicle development, but in either case show 
strong gender-biased expression profiles. 
Oocyte meiosis is arrested at the diplotene stage and awaits resumption of meiosis 
during the later stages of progesterone-mediated oocyte maturation.  CCNB1, CCNB2, 
and CCNA1 all show robust expression around 2WPM when more oocytes are reaching 
the diplotene stage.  CCNB complexed with a serine/threonine kinase (CDC2) mediates 
the G2/M transition when triggered upstream by progesterone (Nebreda and Ferby, 
2000).  Other genes involved in resumption of meiosis are MAPK and WEE1.  Both of 
these genes are represented in this data set by putative homologs showing robust 
expression levels in the ovary starting around 1WPM and 2WPM respectively (MAPK13 
and WEE2).  All of these transcripts are presumably being localized within the diplotene 
oocytes and inactivated prior to the events triggering resumption of meiosis. 
4.2 Testis 
 
 Stage IV of Ogielska and Kotusz’ (2004) staging criteria for Anuran gonad 
development is the point at which the undifferentiated gonad becomes either an early 
ovary or early testis.  Therefore, similar to the ovary at somatic stage NF58, the testis is 
also at stage IV.  This stage of testis development exhibits migration of germ cells and 
mesenchyme cells to the medullar space while the cortex recedes and eventually 
disappears (Ogielska, 2009a).  The mesenchyme cells subsequently differentiate to 
become connective tissue and Leydig cells.  Much uncertainty exists about what factor(s) 
signal germ cell migration toward the medullar space in Anurans ultimately 
differentiating into spermatogonia.  Experimentation with parabiosis, transplanted gonad 
grafts, and steroid hormone exposure brought about a theory that the Anuran testis 
produces substance(s) other than steroid hormones that induce medullary development 
and is also capable of transforming ovaries of genetic females into testes (reviewed by 
Hayes 1998).  Furthermore, the putative inducer substance(s) were later suggested to be 
blood-bound.  This theoretical substance, termed “medullarin” by Chang and Witchi 
(1956), has not yet been identified nor has the mechanism been elucidated.  Interestingly, 
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the mRNA showing the greatest magnitude of differential expression in the entire data set 
is a testis-biased relaxin family protein (rflcii) (Appendix B).  The putative human 
ortholog for this gene is INSL3, which is a Leydig cell-specific insulin-like protein.  Both 
of these proteins belong to the relaxin family of peptide hormones.  This family of 
peptide hormones and their receptors have been implicated in various reproductive 
functions in humans and mice (Bathgate et al., 2013), but their roles in other vertebrates 
have not been well-studied.  Based on our results, we propose that this X. tropicalis 
relaxin peptide hormone is a likely candidate for the unidentified “medullarin” substance 
promoting Anuran testis development. 
 Given that INSL3 is Leydig cell-specific in mammals, it is likely that Leydig cells 
are present in the testis as early as NF58 despite being in the pre-spermatogenesis phase.  
Although fetal Leydig cells have been identified in 7-day-old rat testis tissues by 
immunohistochemical analyses (Svechnikov et al., 2010), histological studies in 
amphibians have not yet specifically identified how early Leydig cells differentiate and 
become influential in testis development.  Our results now provide a precedent for 
“larval” Leydig cells being the amphibian equivalent to mammalian fetal Leydig cells.  
Also supporting the presence of Leydig cells at NF58 is the expression of genes coding 
for androgen-producing enzymes including CYP17A1 and SRD5A2.  Expression of these 
genes become more testis-enriched throughout this period of development.  Another 
notable testis-enriched transcript codes for the CYP26B1 enzyme.  As discussed in 
relation to ovary-enriched CYP26A1 during this period of development, CYP26 enzymes 
are responsible for retinoic acid regulation, which ultimately affects timing of germ cell 
meiosis (reviewed by Bowles and Koopman, 2007).  CYP26B1 expressed in Sertoli cells 
has been found to delay retinoic acid-mediated germ cell meiosis in mice testis tissue 
leading to development of spermatogonia later in reproductive maturation whereas 
Cyp26b1-knockouts exhibited precocious meiosis of germ cells similar to the timing of 
oocyte meiosis (Bowles et al., 2006).  The observed patterns of CYP26 expression in X. 
tropicalis are consistent with what has been found in mammalian embryonic 
development research, emphasizing the conserved critical role of retinoic acid-mediated 
germ cell development. 
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   In a very general sense, the testis-enriched transcripts are expressed at relatively 
constant levels as compared to the ovary-enriched transcripts that show time-dependent 
increases in expression throughout this period of differentiation.  This can be attributed to 
the cellular organization and tissue morphology processes set in motion prior to NF58, 
and continuing until sex cords and ductules of rete testis are fully formed in the weeks 
and months following this period of differentiation.  Orchestration of the various 
morphological changes in the differentiating testis involves signaling within and between 
cells involving extracellular proteins and growth factors (FBLN5, DHH, FGFBP3, 
BMP1, ASTL, DKK3, NPTX1, FGF10, GAS6, INHA, INHBA, KITLG), plasma membrane 
proteins (ADCYAP1, COL13A1, RARRES1, INTGA2B), and transcription factors (DAX-1, 
FHL2, OSR2, SNAI2). 
 Among the aggregation of primary spermatogonia into clusters that eventually 
become sex cords, mesenchymal cells begin to form connective tissue.  Transcripts 
showing some of the highest magnitude of differential expression between testis and 
ovary tissue are BMP1 and a similar gene ASTL, which are both pro-collagen 
metalloproteases (reviewed by Muir and Greenspan, 2011).  Evidence of collagen 
production is further supported by the expression of various collagen isoforms COL8A1, 
COL9A1, and COL13A1.  The recruitment of mesenchymal cells for the formation of 
connective tissue and Leydig cells involves the epithelial-mesenchymal transition (EMT) 
(reviewed by Thiery and Sleeman, 2006).  This process has been shown to involve a 
complex network of signaling involving a series of genes well-represented by this data 
set’s testis-enriched transcripts including a transcription repressor of E-cadherin SNAI2, 
an integrin cell surface receptor INTGA2B, fibroblast growth factor FGF10, and its 
putative activator FGFBP3.  One component of the EMT is Wnt signaling, which is 
regulated in part by three members of the Dickkopf gene family (Krupnik et al., 1999).   
DKK3 is testis-enriched here but has been shown not to function like the other Wnt 
antagonist Dkk isoforms.  Instead, DKK3 is related to a novel secreted protein SGY 
(DKKL1) that has been shown to localize to the acrosome in mammalian spermatocytes 
(Kohn et al., 2005).  However, upon reviewing the original data, DKK1 was testis-
enriched by approximately 2-fold (corrected p < 0.01), supporting antagonist action on 
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the Wnt pathway allowing the EMT to take place in the testis.  During the EMT, 
mesenchymal cells migrate and differentiate into the cells they are fated to become.  This 
cell migration requires cytoskeletal components actin, myosin, and tropomyosin, which 
are all testis-enriched during this period of development (MYH11, TPM2, ACTA2, 
MYL4).  However, whether the cells differentiate into connective tissue or support cells 
for spermatogenesis depends on other signaling factors. 
 One essential signaling factor being expressed in the testis is the desert hedgehog 
gene (DHH).  This gene is expressed in Sertoli cells and is required for proper formation 
of sex cords by interacting with the peritubular myoid cells and inducing Leydig cell 
differentiation (Clark et al., 2000; reviewed by Franco and Yao, 2012).  In fetal mice, 
Leydig cell differentiation is suggested to be triggered by Dhh-mediated steroidogenic 
factor 1 (SF1) up-regulation in cells outside the sex cords (Yao et al., 2002).  A lack of 
Dhh protein in male Dhh-null mice has been shown to cause sterility, while having no 
effect on reproduction in females (Bitgood et al., 1996).  This severity of response 
emphasizes the importance of DHH and associated signaling pathway to testis 
development; its expression pattern in X. tropicalis appears to be consistent with what is 
observed in mammals.  Further investigation into modulation of DHH expression in 
Anurans is necessary as inhibition of this pathway could have major implications on 
successful reproduction.      
 Other notable testis-enriched transcripts in X. tropicalis that have been well-
characterized in mammalian reproductive development include inhibin subunits INHA 
and INHBA, and also DAX-1 (NR0B1).  Inhibins belong to the TGF-β protein superfamily 
and are multifunctional hormones involved in control of FSH secretion from the pituitary 
and also paracrine/autocrine signaling within the human testis (Luisi et al., 2004).  In the 
fetal human testis, INHA is expressed in Sertoli cells and both INHA and INHBA are 
expressed in Leydig cells.  However, inhibin B is the subunit expressed later in 
development that is used clinically as a diagnostic indicator of Sertoli cell function, 
spermatogenesis, and fertility (Pierik et al., 1998).  Therefore, it is clear INHA and 
INHBA are playing roles in early gonadogenesis, presumably consistent with mammalian 
testis development, but currently lack correlation with fertility.   
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Finally, DAX-1 is a multifunctional orphan nuclear receptor protein that, with 
duplication, is capable of causing male to female sex reversal in mammals with a normal 
SRY gene (Lalli and Sassone-Corsi, 2003).  It has been shown to play many regulatory 
functions within steroidogenic tissues through various mechanisms including DNA 
binding to transcription activation sites, recruitment of co-repressors, and interaction with 
the androgen receptor and estrogen receptors α and β.  DAX-1 has been shown to directly 
interact with steroidogenic factor 1 (SF1) negatively regulating transcription of 
steroidogenic enzymes including CYP17, CYP19, and others (Gurates et al., 2002; 
Hanley et al., 2001; Wang, Z.J. et al., 2001).  Inhibin α (INHA) discussed previously has 
also been shown to be negatively regulated either directly or indirectly by DAX-1 
(Achermann et al., 2001a).  Therefore, the expression pattern of DAX-1 in X. tropicalis 
testis tissue during these stages of development is very curious, as the sex determining 
gene has not been found in this species (it is not known to have functional SRY) and 
expression levels of CYP17 and inhibin α appear to be uninhibited.  However, CYP19 
expression in the testis is low to absent suggesting a plausible mechanism for maintaining 
a masculine tissue during this period of development.  The DAX-1 expression pattern in 
X. tropicalis testis tissue is consistent with DAX-1 expression patterns in Rana rugosa 
(Sugita et al., 2001) indicating the importance of this transcript in frog testis development 
despite it being an “anti-testis” gene in mammals.  This gene’s key activities and diverse 
mechanisms, within and between species, make it a particularly interesting candidate for 
further investigations regarding cross-species differences in reproductive development.  
 
5. Conclusion 
 
The wealth of expression data was generated by this experiment. While the 
analysis and discussion was focused on transcripts with greater than 5-fold (corrected p < 
0.01) differential expression between tissues, many other transcripts showing gender-
biased expression remain to be explored.  Robust expression profiles of key transcripts 
previously characterized in gonad development and the comprehensive representation of 
the various well-known developmental processes involved in gonad differentiation 
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emphasize the quality of this data set.  Although limited to consideration of 
transcriptional differences, these data provide many insights into cross-species 
similarities of expression profiles specific to gonadal development, differentiation, and 
fertility.  This work has generated numerous testable hypotheses and provides a 
foundation for subsequent investigations of chemical-induced perturbations of pathways 
proximal to molecular initiating events.  Linking these molecular initiating events to 
adverse effects on the reproductive organs will identify vulnerable targets of 
environmental pollutants, aid in elucidation of adverse outcome pathways, and have 
potential for cross-species extrapolation and population modeling. 
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Chapter 2. Measuring testis dysgenesis using gene expression 
biomarkers in Xenopus laevis following exposure to prochloraz.   
 
1. Introduction 
   
The anti-androgenic effects of prochloraz in other species provided precedent to 
utilize this model chemical to evaluate expression-based biomarkers of testis dysgenesis.  
Prochloraz is an imidazole fungicide shown to have multiple mechanisms of action 
within the HPG axis.  In vitro studies have shown that prochloraz has characteristics of 
both an antagonist of the androgen receptor and inhibitor of aromatase activity (Noriega 
et al., 2005; Villeneuve et al., 2007; Vinggaard et al., 2002).  In adult fish, in vivo 
exposure to prochloraz produces effects that are consistent with inhibition of aromatase 
(Ankley et al., 2005).  Further, developmental exposure in rats produces a spectrum of 
male reproductive tract malformations which have been attributed to anti-androgenic 
properties (Noriega et al., 2005; Blystone et al., 2007; Vinggaard et al., 2002).  
Interestingly, females were not affected by developmental exposure in the 
aforementioned studies.   
In an attempt to better elucidate the anti-androgenic mode of action, careful 
selection of specific genes proximal to the androgenic regulatory network was warranted.  
The gene array study presented in Chapter 1 provided a foundation for selection of 
candidate genes exhibiting robust, statistically testis-biased expression profiles as a 
starting point.  Specific genes were then identified as potential indicators of biological 
response at different points within and around the putative androgen molecular network.  
Specifically, genes were selected that have precedent for being (1) directly regulated by 
androgen/androgen receptor (Insl3/rflcii), (2) mainly responsible for producing 
endogenous androgen (Cyp17a1), (3) an endogenous suppressor of androgen receptor 
activity (Dax-1), and (4) suppressed by active androgen/androgen receptor signaling 
(Sox9b).   
 Relaxin family locus C type 2 (rflcii) is orthologous to the mammalian insulin like 
protein INSL3.  INSL3 is a Leydig cell-specific peptide hormone responsible for testis 
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descent in mammals and plays a role in follicle selection in the adult ovary (Bathgate et 
al., 2013).  In the gene array study presented in Chapter 1, Xenopus tropicalis rflcii was 
the transcript showing the highest normalized expression level overall, which was also 
the most differentially expressed transcript between ovary and testis tissue.  This 
profound difference in expression between tissues provides early evidence of this gene’s 
importance in Xenopus testis development.  Furthermore, mammalian Insl3 has been 
shown to be positively regulated by testosterone/androgen receptor.  It also contains an 
androgen responsive element in its promoter region and anti-androgen mono-(2-
ethylhexyl) phthalate inhibits testosterone-induced Insl3 expression (Laguë and 
Tremblay, 2008).  Given this information, I hypothesized that the anti-androgen 
prochloraz would cause a decrease in testis expression levels of rflcii. 
 Cytochrome P450 (CYP) c17α-hydroxylase/17,20-lyase (CYP17) is an enzyme 
necessary for the production of steroid hormones.  This key steroidogenesis enzyme is 
highly conserved across species.  The Cyp17a1 transcript exhibited testis-biased 
expression in the gene array study (Chapter 1) and is generally associated with 
testosterone production, even though estrogen production proceeds through this same 
pathway.  Prochloraz not only inhibits androgen receptor, but also inhibits CYP17 
(Blystone et al., 2007; Noriega et al., 2005; Vinggaard et al., 2002) and other CYPs due 
to the imidazole interaction with iron.  The inhibition of ergosterol synthesis by this 
interaction with 14α-demethylase (CYP51) is what gives prochloraz its antifungal 
properties (Van den Bossche et al., 1978).  Therefore, CYP17 inhibition by prochloraz 
could be a major contributor to its anti-androgenic effects.  Given the importance of this 
enzyme for testosterone production and the potential for inhibition by prochloraz, I 
hypothesized that prochloraz exposure would increase expression of CYP17 in the testis 
due to a compensatory response. 
   Dax-1 (NR0B1) is a nuclear receptor that has been shown to play a substantial 
role in mammalian gonad development as a transcriptional repressor of steroidogenesis 
(Zazopoulos et al., 1997).  In mammals, duplication and over-expression of this gene 
causes male-to-female sex reversal, but loss of DAX-1 function in knockout mice does 
not affect normal ovary development, which is why it has been referred to as an “anti-
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testis” gene (Muscatelli et al., 1994; Yu et al., 1998a; Zanaria et al., 1994).  Early in 
Xenopus tropicalis gonad development, Dax-1 expression is testis-enriched (Chapter 1), 
and is consistent with expression profiles in Rana rugosa (Sugita et al., 2001) indicating 
that Dax-1 also plays an active role in anuran testis development.  In addition to its 
repressive effects on steroidogenesis, mammalian DAX-1 protein has been shown to bind 
to androgen receptor inhibiting its transcriptional activity (Holter et al., 2002), presenting 
as an endogenous anti-androgen.  However, steroidogenic factor 1 (SF-1), a 
transcriptional regulator of many genes involved in steroidogenesis and key determinant 
of endocrine differentiation and function (Parker et al., 2002), has been shown to bind the 
murine Dax-1 promoter, stimulating its expression (Yu et al., 1998b).  DAX-1 protein 
then antagonizes SF-1-mediated gene activation (Guarates et al., 2003; Nachtigal et al., 
1998), presenting as an SF-1 self-regulatory mechanism.  Other mechanisms of Dax-1 
regulation have also been demonstrated but are cell/tissue-specific and developmentally-
specific.  Down-regulation of Dax-1 transcription in adult rat Sertoli cells has been shown 
to be regulated by pituitary FSH through the cAMP signaling pathway (Tamai et al., 
1996) and up-regulated in the differentiating ovary through the Wnt4/β-catenin pathway 
(Mizusaki et al., 2003).  Because of the potent suppressive capabilities of Dax-1 protein 
on androgen receptor and SF-1-mediated steroidogenesis, up-regulation of this gene by 
prochloraz through an unknown mechanism could be a contributing factor to apical 
manifestations of anti-androgenic action.  However, without precedent for a plausible 
mechanism by which this could occur, I hypothesize that expression of Dax-1 will not be 
affected by prochloraz exposure. 
 SRY (sex-determining region Y)-box 9 (Sox9) is an important transcription factor 
that regulates testis development (reviewed by Koopman et al., 2001).  Although this 
gene was discovered in the XY sex determination system, it is conserved across species 
and is also active in the ZW sex determination system (Xenopus).  The weight of 
evidence surrounding Sox9 behavior in testis development across species implies that it is 
a pivotal sex-determining gene, regardless of the genetic switch that activates its 
expression.  In mammalian Sertoli cells it has been shown to interact with steroidogenic 
factor 1 (SF-1) protein as a cofactor for anti-Müllerian hormone (AMH) gene activation 
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(De Santa Barbara et al., 1998).  It has also been shown that androgen/androgen receptor 
signaling has a repressive effect on Sox9 expression in vitro (Lan et al., 2013). 
Supporting this relationship, circulating AMH in humans during pubertal development 
has been shown to be negatively correlated with circulating testosterone (Rey et al., 
1993) and lack of androgen receptor expression in human Sertoli cells during early testis 
development was found to account for high levels of AMH (Boukari et al., 2009).   
AMH mediates Müllerian duct regression in male reproductive development and 
absence of AMH causes “default” maturation of Müllerian ducts in females with 
subsequent disappearance of male-specific Wolffian ducts (Kelley, 1996).  Normal 
Xenopus laevis males exhibit Müllerian duct (oviduct) regression around two months 
post-metamorphosis implying that AMH expression is active – possibly mediated by 
SOX9.  Although the Sox9 expression profile is not presented in Chapter 1, it was indeed 
differentially expressed in two week post-metamorphosis Xenopus tropicalis testis tissue 
compared to ovary tissue by almost 3-fold (Welch’s t-test, p < 0.01).  If prochloraz 
inhibits androgen receptor and testosterone production, one would expect uninhibited 
Sox9 expression with possible dose-dependent acceleration of AMH-mediated oviduct 
regression.  However, accelerated oviduct regression would generally be considered an 
androgenic or anti-estrogenic effect, inconsistent with the previously observed anti-
androgenic effects of prochloraz.  Regardless of this contradiction, I hypothesize that 
inhibition of androgen receptor and testosterone production will cause Sox9 expression to 
increase with prochloraz treatment. 
 Gonad differentiation and development is orchestrated by the complex interplay 
of many different genes and gene networks.  The selection of these four genes to evaluate 
as expression markers of testis dysgenesis following exposure to an anti-androgen is an 
initial step toward better understanding this chemical mode of action in amphibian gonad 
development.  These genes are not well-characterized in amphibians and much is 
unknown about their developmental expression or molecular interactions within Xenopus.  
Ideally, the results from this experiment will not only inform the anti-androgenic mode of 
action in Xenopus, but will also inform species differences in regulation of these genes 
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important to gonad development and help to identify species-specific targets susceptible 
to chemical perturbations. 
       
2. Materials and methods 
2.1 Experimental design 
 
Xenopus laevis embryos (≤ NF stage 15) were exposed to four different chemical 
concentrations and control water until two months after the median time to NF stage 66 
in controls (See Nieuwkoop and Faber 1994 for staging details).  There were five 
replicates in each test concentration with eight replicates for the control.  Endpoints 
evaluated during the course of the exposure included those indicative of generalized and 
metabolic toxicity: mortality, abnormal behavior, growth determinations (length and 
weight) and histopathology of the juvenile liver and kidney.  In addition, endpoints 
indicative of endocrine-specific toxicity were evaluated including larval thyroid 
histopathology, and juvenile histopathology of gonads and reproductive ducts.  Either the 
right or left gonad was chosen randomly for histopathological evaluations while total 
RNA was extracted from the contralateral gonad for gene expression measurements.  
Genotypic/phenotypic sex ratios were also determined. 
2.2 Test concentrations 
 
Test concentrations were chosen deliberately to perturb the endocrine system and 
cause measurable effects on organ morphology and/or levels of endocrine-mediated 
biochemical indicators.  The high test concentration was set based on range finding 
experiments conducted by MED.  In those studies conducted with X. tropicalis, 
concentrations in excess of 200 µg/L resulted in mortality in early larval organisms.  
Therefore, the high test concentration was set at 180µg/L with a 0.33 dilution factor 
resulting in nominal test concentrations of 180, 60, 20 and 6.7µg/L. 
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2.3 Environmental conditions 
 
Organisms were cultured in Lake Superior Water (LSW) initially filtered through 
sand, UV sterilized and filtered again to 5 µm before entering the in-house culture or 
exposure aquaria.  Source water was tested on a yearly basis for contaminants including 
copper, chlorine, chloramine, estrogenic or androgenic chemicals, fluoride, perchlorate 
and chlorate as measurable levels of any of these compounds could confound results of 
the bioassay.  Larvae were held at 21oC throughout the duration of the exposure by 
controlling the temperature of the delivery/dilution water and also by a water bath in 
which the exposure tanks were partially submerged.  Dissolved oxygen, pH and 
conductivity were measured in all exposure tanks once per week throughout the duration 
of the test whereas alkalinity and hardness were measured once per month in one 
replicate tank per treatment (Table 2.1).  There were no treatment-related effects on any 
water quality parameters.  A 12 hour light and 12 hour dark cycle was used with 
fluorescent lighting at intensities between 600 and 2,000 lux (lumens/m2) at the water 
surface.  Exposure tanks were randomly assigned to positions within each exposure 
system to reduce potential effects manifested by systematic differences in environmental 
conditions including slight temperature variations or light intensity. 
 
Table 2.1.  Measured water quality parameters throughout the duration of prochloraz exposure.  Mean ± SD. 
Temperature  
(oC) 
D.O.         
(% sat.) 
pH Alkalinity        
(mg/L CaCO3) 
Hardness           
(mg/L CaCO3) 
Conductivity 
(μS) 
21.0 ± 0.4 76.9 ± 15.2 7.45 ± 0.44 42.4 ± 1.7 47.0 ± 0.8 98 ± 2 
    
2.4 Exposure system 
 
The exposure dilution system consisted of a series of single drive/dual head 
metering pumps (Fluid Metering Inc., Syosset, NY) through which both diluent and 
toxicant flowed to make a single concentration in a stainless steel mixing cell.  Flow-
through conditions were maintained by delivering toxicant and control LSW solutions to 
the 6.5L exposure tanks at a constant rate of 44 mL/min with multichannel peristaltic 
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pumps in order to meet or exceed 9.5 tank turnovers per day.  Wetted surfaces were 
strictly glass, Teflon®, Pharmed® tubing, or stainless steel. 
2.5 Chemical stock preparation 
 
18 mg/L prochloraz stock solutions were prepared by dissolving the neat material 
(Sigma-Aldrich, CAS 67747-09-5, purity: 99.1%) in 20 mL of high purity acetone and 
quantitatively transferring to a 19 L carboy.  The side walls of the carboy were rinsed 
with acetone and it was carefully tipped onto its side and placed on a roller.  Filtered and 
desiccated compressed air was gently blown into the bottle as it was rolled to evaporate 
the acetone and “shell coat” the carboy with prochloraz.  Once the acetone was 
completely evaporated, the carboy was filled with reverse osmosis water and stirred 
overnight to dissolve the prochloraz. 
2.6 Analytical chemistry1 
 
Water samples (~1 mL) were collected weekly from the prochloraz exposure 
tanks (0, 6.7, 20, 60 and 180 µg/L) and placed into amber sample vials.  The water 
samples were amended with 0.1 mL methanol, vortex mixed and immediately analyzed 
using an Agilent 1100 series high performance liquid chromatograph (HPLC) with diode 
array detection (λ = 205 nm).  An aliquot  (150 µL) of sample was injected directly into a 
Zorbax SB-C18, 2.1 x 75 mm column (Agilent, Wilmington, DE, PN# 866735-902) that 
was maintained at 25°C.   The auto sampler temperature was maintained at 5°C.   
Prochloraz eluted from the column under isocratic conditions with 22% Burdick & 
Jackson (B&J) HPLC grade water and 78% methanol at 0.3 mL/min.  Prochloraz 
concentrations were determined by the external standard method of quantification using 
linear regression.  Prochloraz standards range from 5 to 200 µg/L and were prepared in 
90% B & J water and 10% methanol.  Quality assurance samples were conducted with 
each sample set and included Lake Superior water (LSW) blanks, duplicate samples and 
matrix spiked samples at each of the prochloraz treatment levels.  No prochloraz was 
detected in the LSW blanks (n = 15).  Mean ± SD (n = 15) recoveries of spiked samples 
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were 102.2 ± 3%, 99.5 ± 2.5%, 99.3 ± 2.5% and 100.7 ± 2.2% at the 6.5, 20, 60 and 180 
µg/L spiked levels, respectively. Mean ± SD (n = 15) agreement among duplicate 
samples were 99.8 ± 1.9%, 99.3 ± 3.3%, 99.4 ± 1.5% and 100.3 ± 1.5%  for the 6.7, 20, 
60 and 180 µg/L treatments, respectively.  The detection limit was 2.5 µg/L. 
1Analytical chemistry was performed by Patricia Kosian (USEPA, Duluth, MN) 
2.7 Test initiation 
 
All animal care and use procedures for these experiments were reviewed and 
cleared by the division Animal Care and Use committee.  Adult in-house breeding pairs 
were induced by injection of 750 IU human chorionic gonadotropin (Sigma-Aldrich, St. 
Louis, MO, USA) into the dorsal lymph sac of each male and female and were allowed to 
enter amplexus in static 10L tanks filled with 6L of culture water.  Eggs were collected 
and jelly coats were removed by L-cysteine treatment approximately 14-16 hours after 
pairing.  A 2% L-cysteine solution was prepared and pH adjusted to 8.1 with 1N NaOH.  
This 21oC solution was added to a 500 mL Erlenmeyer flask containing the eggs from a 
single spawn and swirled gently for one to two minutes and then rinsed thoroughly 6-8 
times with culture water.  The spawn was transferred to a crystallizing dish and 
determined to be >70% viable with minimal abnormalities in embryos exhibiting cell 
division.  Embryos were carefully screened for any cellular or superficial abnormalities 
and then sorted by stage and distributed evenly into each of 28 - 250 mL glass beakers 
containing approximately 20 mL of culture water.  Each beaker contained 26 embryos to 
be added to each exposure tank.  An attempt was made to initiate exposure at or before 
NF stage 8, but screening and distribution efforts delayed initiation of exposure until no 
later than NF stage 15.  At test initiation, beakers containing the embryos were carefully 
submerged in the exposure tank solution and set on the bottom of the tank.  This 
technique kept the embryos localized within the beaker until they were able to swim out 
into the tank on their own and allowed for simple observations of embryonic 
development.  The beakers were positioned directly under the test solution delivery line 
to facilitate solution renewal and flow through the beaker.  When all of the organisms had 
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left the beakers, the beakers were removed from the exposure tanks.  Observations of 
arrested embryonic development were recorded prior to hatch, and mortality and 
abnormal behavior were recorded daily throughout the duration of the exposures. 
2.8 Feeding   
 
Larvae were fed a liquid diet three times per day on weekdays and once per day 
on weekends starting on day 4 post-fertilization.  The diet consisted of Silver Cup Trout 
Starter (Nelson and Sons, Murray, UT, USA), Spirulina algae discs (Wardley, Secaucus, 
NJ, USA) and TetraFin® flakes (Tetra Sales, Blacksburg, VA, USA) blended together in 
culture water.  Tadpoles were also fed 24-hour old live brine shrimp (Bio-Marine® 
Brand, Bio-Marine, Hawthorne, CA, USA) twice daily on weekdays and once daily on 
the weekends starting on day 8 post-fertilization.  Brine shrimp nauplii were hatched 
overnight and separated from cyst casings with appropriately sized screen filters before 
use.  Feeding was increased weekly until the majority of individuals in any given tank 
developed to NF stage 62 at which time food was decreased proportionately.  When 
individuals completed metamorphosis (NF66), the diet was changed to 3/32” premium 
sinking frog food pellets (Xenopus Express, Plant City, FL, USA) until test termination. 
2.9 Larval sub‐sampling   
 
Larval sub-sampling was performed by dividing the exposure tank and separating 
individuals that reached NF66 from individuals that had not yet reached NF66 and 
recording the date on which each individual completed metamorphosis.  One out of each 
group of four consecutive individuals completing metamorphosis in any given tank was 
randomly sampled for growth metrics including weight and snout-to-vent length, and 
thyroid histopathology.  At any given time during metamorphosis, developmental stages 
of organisms within an experimental unit are generally normally distributed.  This larval 
sub-sampling method was intended to reduce bias toward sampling individuals on the 
leading or tailing edges of development in a particular tank by spreading the sampling out 
over time.  That way all individuals in a tank had equal likelihood of being sampled upon 
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reaching NF66.  Sub-sampled individuals were euthanized by submersion in 200 mg/L 
tricaine methanesulfonate ([MS-222], Argent Chemical Laboratories, Redmond, WA, 
USA) buffered with 400 mg/L sodium bicarbonate.  Following growth measurements, a 
transverse cut was made at the posterior margin of the arms for decapitation and the head 
was fixed in Davidson’s solution for thyroid histopathology.  Individuals not sampled 
were left in the divided tank until all individuals had reached NF66 or day 70, at which 
time the tank dividers were removed and any larvae that hadn’t reached NF66 were 
euthanized by immersion in MS-222.  The purpose of the larval sub-sample is to evaluate 
the chemical’s effect on the hypothalamic-pituitary-thyroid axis, which is outside the 
scope of this thesis.  Therefore, methods or results related to the larval sub-sample 
endpoints will not be discussed.  
2.10 Cull 
 
Two to three weeks following the time at which all individuals completed 
metamorphosis (NF66), a cull was performed to reduce tank density and ideally result in 
five males and five females remaining in each tank until test termination.  Toe clips were 
taken from every individual on test in a manner where they could be uniquely identified 
based on tank ID and toe clip scheme.  These toe clips were analyzed for the presence or 
absence of DM-W in order to determine genetic sex (described in later section).  An even 
number of males and females were randomly selected to remain in the tank and the 
remaining juveniles were euthanized by i.p. injection of 100 mg/mL MS-222 dissolved in 
phosphate buffer (pH 7.4).  
2.11 Juvenile sampling (test termination) 
 
When the study was terminated, endpoint measurements were collected on all 
juveniles immediately following euthanasia by i.p. injection of MS-222.  Juveniles were 
weighed and measured for snout-to-vent length; the abdomen was opened and the liver 
was carefully removed intact, weighed, placed in a labeled cassette and transferred into 
Davidson’s fixative.  Subsequently, the remaining internal viscera was removed and 
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discarded with taking care to leave the gonads, kidneys and reproductive ducts 
undamaged and in situ for fixation.  One of the gonads was randomly chosen to be 
removed for gene expression analysis, homogenized in lysis buffer from an RNeasy Plus 
kit (Qiagen Inc., Valencia, CA, USA), and immediately frozen on dry ice until samples 
could be moved to -80oC storage.  Gonad phenotype was recorded and a foot was 
removed and frozen for genetic sex determination.  The torsos containing a gonad, 
kidneys and reproductive ducts were placed in individually labeled cassettes and 
transferred to Davidson’s fixative.       
2.12 Histological procedures 
 
All tissues preserved for histological analyses were initially fixed in Davidson’s 
fluid for 48 hours with constant mixing and at least 10x the volume of fixative relative to 
the volume of tissue.  After approximately 48 hours, tissues were removed from 
Davidson’s, rinsed with tap water and stored in 10% neutral buffered formalin.  Tissues 
were shipped in neutral buffered formalin to Integrated Laboratory Systems, Inc. (ILS®), 
Research Triangle Park, NC, USA, where they were processed, embedded, sectioned, 
mounted and stained with hematoxylin and eosin (H&E) using typical histological 
procedures.  Histopathologic findings were scored for severity by an ILS® pathologist 
according to the following grading system:  X = not remarkable, Grade 1 = minimal (less 
than 10% of tissue affected), Grade 2 = mild/slight (≥10% but less than 40% of tissue 
affected), Grade 3 = moderate (≥40% but less than 80% of tissue affected), and Grade 4 = 
severe (≥80% of tissue affected).  However, for the purposes of this thesis, data is 
presented as incidence, regardless of severity.  The juvenile livers were embedded in their 
entirety and 200µm step sections were taken until the largest possible cross-sectional area 
was reached.  Two 4µm thick sections were mounted on a single slide per individual, 
stained with H&E and evaluated by brightfield microscopy for pathology.  The juvenile 
gonad, kidney and reproductive ducts were left in situ and were processed, sectioned and 
evaluated within the same sections.  Torsos were trimmed transversely at the anterior and 
posterior margins of the gonads, and then the gonads were measured on the anterior-
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posterior axis and bisected transversely in the exact center to yield two equally sized 
sections – one anterior and one posterior.  Each section was embedded in a separate mold 
in order to efficiently obtain sections representative of the anterior, middle and posterior 
regions of the gonad.  This was done to evaluate differences in sensitivity to chemical 
exposure between regions of the gonad due to evidence of the gonad differentiating along 
an antero-posterior gradient in Xenopus tropicalis (El Jamil et al. 2008).  This regional 
comparison is beyond the scope of this thesis and will not be discussed.  Data presented 
herein are incidences of a particular pathology in any of the three sections.      
2.13 Genetic sexing 
 
A hind limb from each individual was frozen at -20oC until DNA could be 
purified using DNeasy kits (Qiagen Inc., Valencia, CA, USA) according to kit 
instructions.  Testing for the presence or absence of the Xenopus laevis W-linked marker 
(DM-W) was performed by PCR based on the method described by Yoshimoto et al. 
(2008).  DMRT1 was also amplified in duplexed PCR reactions as a housekeeping gene.   
2.16 Testis RNA processing 
 
Total RNA was isolated from testis homogenates using RNeasy Plus mini kits 
(Qiagen Inc., Valencia, CA, USA) according to kit instructions.  RNA concentrations 
were initially measured on a NanoDrop ND-1000 Spectrophotometer (NanoDrop 
Technologies, Inc., http://www.nanodrop.com).  However, several factors warranted a 
more accurate determination of RNA concentrations: (1) low and variable yield, (2) the 
need to pool tank samples with equal representation of each individual, and (3) the use of 
total RNA concentrations to normalize expression values.  To this end, a fluorescence-
based RNA quantitation assay was performed on three samples randomly chosen per tank 
(Quant-iTTM Ribo-green®, Life Technologies, Grand Island, NY, USA).  Samples 
showing less than 2ng/µl concentrations according to NanoDrop results were avoided if 
possible.  One tank from the 20µg/L prochloraz treatment was excluded from subsequent 
analyses due to extremely low yields from all testis samples.  RNA quality was checked 
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on all chosen samples using a 2100 Bioanalyzer with an RNA 6000 pico assay (Agilent, 
Santa Clara, CA, USA).  If samples had obvious issues with integrity, a new sample was 
randomly chosen from that tank and its concentration and integrity were measured prior 
to pooling.  The three samples per tank were then diluted to between 0.5 and 1ng/µl 
(depending on the lowest concentration of the three samples to be pooled) and combined 
in equal amounts to create one pool per tank.  Each pool was divided into multiple 
aliquots to avoid freeze/thaw cycles and a new total RNA concentration was determined 
for each pool using the same fluorescence method previously described.  All subsequent 
gene expression levels were normalized to the total RNA concentration in each respective 
pool. 
2.17 Quantitative PCR 
 
X. tropicalis accession numbers from four testis-enriched genes were aligned with 
the NCBI EST database for X. laevis using the nucleotide Basic Local Alignment Search 
Tool (http://blast.ncbi.nlm.nih.gov/Blast.cgi).  The highest scoring sequences were used 
to design primers and probes for use in a TaqMan® EZ RT-PCR assay (Applied 
Biosystems®) (Table 2.1).  Primers and probes were designed using Primer Express 
version 3.0 (Applied Biosystems®).  Standard RNA templates were generated by first 
generating cDNA and amplifying the target sequence using outer primers with a one-step 
reverse-transcription PCR kit (Enhanced Avian HS RT-PCR kit; Sigma-Aldrich).  Next, 
target cDNA was amplified using separate primers that flanked the qPCR primers and 
contained the T7 promoter region for subsequent in vitro transcription using a 
MEGAScript kit (Ambion®) according to kit instructions.  Transcribed RNA template 
concentrations were determined using the mean of three measurements from a NanoDrop 
ND-1000 Spectrophotometer.  Pooled samples were run in 96-well plates according to 
TaqMan® kit instructions on an Agilent Strategene Mx3005P real-time quantitative PCR 
instrument.  Standard curves and data were acquired from MxPro –Mx3005P9® software 
version 4.10 Build 389, Schema 85 (Stratagene). 
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Table 2.2.  Accession numbers, primer and probe sequences used for quantitative PCR of selected gene transcripts. 
Gene 
symbol 
X. tropicalis 
accession 
X. laevis 
accession Primers (5' -> 3') Probe (5' -> 3') 
Cyp17a1 NM_001127045.1 NM_001097071.2 For:  CCACGTGCTGTGACAACAGATA ACATTGCTTTCGCCAACTACAGCCCA 
Rev:  GCACTACCTTGCGGTGAAACT 
rflcii NM_001126835.1 CV081081.1 For:  TGACACCATGGAACAGTTGCA TAGGTCAAGAACCACGGAGCACCAGC 
Rev:  CCGCACTCCTCCTCATCCT 
Sox9b NM_001016853.2 NM_001094473.1 For:  TCCGTGATGTGGACATTGGT AGTGAGGTCATCTCCACCATCGAAACCTT 
Rev:  GGCAGGTACTGGTCAAATTCATT 
Dax-1 XM_002933615.2 AB273178.1 For:  GGCTTGCACTGCATCCAGTA CAAGGACTACAGCATGAAGCTCAACAAGCA 
Rev:  GTGAATCATCTTGATGTGTTCGTTT 
  
2.18 Statistics 
 
All data from juveniles were analyzed separately according to genetic sex.  
Continuous data (e.g. weight, length, LSI, mortality, gene expression) was checked for 
monotonicity by rank transforming the data, fitting to an ANOVA model and comparing 
linear and quadratic contrasts.  All data was monotonic, so a step-down Jonckheere-
Terpstra trend test was performed on replicate medians.  Mortality data was analyzed for 
the time period encompassing the full test and was expressed as percent that died in any 
particular tank. Tadpoles that did not complete metamorphosis in the given time frame, 
those tadpoles that were in the larval sub-sample cohort or that were culled, and any 
animal that died due to experimenter error was treated as censored data and not included 
in the denominator of the percent calculation.  Prior to any statistical analyses, mortality 
ratios were arcsin-square root transformed and analyzed as described above.  Gene 
expression data was expressed as copies mRNA per ng of total RNA and was only log-
transformed prior to analysis if values spanned multiple orders of magnitude.  Otherwise, 
these data were not transformed prior to analyses. 
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3. Results 
3.1 Test concentrations 
 
Mean ± SD (n = 75) measured concentrations of the 6.7, 20, 60 and 180 µg/L 
treatments were 6.10 ± 0.69, 18.11 ± 2.14, 52.83 ± 5.90 and 169.76 ± 14 µg/L, 
respectively, over the duration of the experiment.  Among-tank variability was ≤ 12% 
with the coefficient of variation (averaged across the duration of the experiment) of 
11.4%, 11.8%, 11.2% and 8.2 %, respectively for the 6.7, 20, 60 and 180 µg/L 
treatments.  No prochloraz was detected in the control water treatments. 
3.2 Generalized toxicity (survival, growth, liver and kidney pathology) 
 
Prochloraz treatment did not affect survival in either gender (data not shown) and 
did not significantly affect growth in females (Table 2.3); although, mean female weights 
with prochloraz treatment were all greater than the control mean weight.  Male mean 
weights in all prochloraz treatments were slightly less than the mean control weight and 
the 180 µg/L treatment was statistically lower than control (p < 0.05, Jonckheere-
Terpstra; Table 2.3).  Liver-somatic indices were significantly lower in the 60 µg/L and 
180 µg/L treatments in both genders (p < 0.05, Jonckheere-Terpstra; Table 2.3).  
Histopathological evaluations identified an increase in incidence and severity of 
hepatocellular degeneration, consistent with the decrease in liver-somatic indices.  
Minimal to moderate hepatocellular degeneration occurred in prochloraz exposed frogs at 
an incidence of 10% (2/20 frogs) for the 20 µg/L treatment, 35% (7/20 frogs) for the 
60µg/L treatment and 100% (20/20 frogs) for the 180 µg/L treatment (Figures 2.1 & 2.2).  
In kidneys of 30 (60%) animals from the 180 µg/L treatment, large numbers of renal 
tubules contained ~12µm, irregularly oval, amphophilic intracytoplasmic bodies 
(inclusions) (Figure 2.3).  Minimal (infrequent) accumulations of protein within the 
Bowman’s capsule were observed in all study groups with a slightly higher percentage of 
animals affected in the 180 µg/L treatment: 1% (1/80) of control frogs, 4% (2/51) of 
frogs from the 6.7 µg/L treatment, 4% (2/46) of frogs from the 20 µg/L treatment, 4% 
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(2/50) of frogs from the 60 µg/L treatment, and 16% (8/50) of frogs from the 180 µg/L 
treatment (Figure 2.3). 
 
 
Table 2.3.  Mean ± standard deviation for growth and LSI measurements in control and prochloraz-treated Xenopus 
laevis.  Asterisk (*) represents statistical significance at p < 0.05 (Jonckheere-Terpstra) 
Male 
Control  
(n = 8) 
6.7 µg/L  
(n = 5) 
20 µg/L  
(n = 5) 
60 µg/L  
(n = 5) 
180 µg/L  
(n = 5) 
Weight (g) 13.2 ± 2.2 12.5 ± 2.6 11.8 ± 2.8 12.5 ± 2.3 12.5 ± 2.7* 
Snout-to-vent length (mm) 47 ± 3 46 ± 3 45 ± 4 46 ± 3 46 ± 4 
Liver-somatic index 0.059 ± 0.010 0.056 ± 0.012 0.055 ± 0.012 0.051 ± 0.007* 0.050 ± 0.004* 
Female 
Weight (g) 12.9 ± 2.6 13.8 ± 3.4 14.1 ± 2.3 13.9 ± 2.5 13.3 ± 2.8 
Snout-to-vent length (mm) 47 ± 3 48 ± 4 48 ± 2 48 ± 3 48 ± 4 
Liver-somatic index 0.061 ± 0.007 0.056 ± 0.013 0.06 ± 0.007 0.052 ± 0.005* 0.052 ± 0.005* 
 
 
 
 
  
Figure 2.1.  Histological sections of control liver tissue at two months post-metamorphosis.  (A) 20X 
normal control liver.  Hepatic cords are two cells thick (arrow) separated by bile canaliculus; hepatocyte 
cytoplasm is wispy and eosinophilic (arrowhead). (B) 60X normal control liver, higher magnification. Note 
wispy eosinophilic cytoplasm (arrowhead) and condensed (basophilic) cytoplasm adjacent to bile 
canaliculus (arrow). 
 
 
A B
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Figure 2.2. Histological sections of 180 µg/L prochloraz-treated livers at two months post-metamorphosis.  
(A) 20X 180 µg/L treated liver exhibiting moderate hepatocellular degeneration.  Cytoplasmic inclusions 
are present within many hepatocytes (arrows); inclusion location is often pericanalicular (arrows).  (B) 60X 
– higher magnification of (A). Degenerative hepatocytes are smaller and contain pericanalicular inclusions 
(arrows); note prominent bile canaliculus (arrowhead).  (C) 20X – another example of a 180 µg/L treated 
liver exhibiting moderate hepatocellular degeneration.  Degenerative hepatocytes containing cytoplasmic 
inclusions may be swollen (arrows); hepatic cords appear jumbled.  (D) 60X – higher magnification of (C).  
Inclusions often consist of “punctuate” granular material (arrow); note smudgy basophilic material at 
periphery of inclusion (arrowhead). 
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Figure 2.3. Histology sections of control and prochloraz-treated kidneys at two months post-
metamorphosis.  Control kidney, 10X(a) and 20X(b).  Normal kidney.  Profiles of the thick limb of the loop 
of Henle (red arrows) fill the cortex; glomeruli (blue arrows) and collecting tubules (green arrows) are 
largely confined to the cortex.  Small cluster are myeloid cells are present (black arrows) and large numbers 
of red blood cells (yellow arrows) fill the interstitium.  (c) 180µg/L study group, 60X. Intracytoplasmic 
amphophilic inclusions. Renal tubular cells contain large, irregular, intracytoplasmic, amphophilic 
inclusions (red arrows).  (d) 60µg/L study group, 40X. Glomerular protein, Grade 1. The Bowman’s 
capsule of several glomeruli contains small accumulations of pale, eosinophilic material (black arrows). 
 
3.3 Endocrine toxicity (gonad, duct, gene expression) 
 
Testis histopathology evaluations revealed a series of effects from prochloraz 
exposure mainly in the 180 µg/L treatment (Table 2.4).  Separate assessments were made 
for gonadal degeneration that presented as germinal epithelial thinning/loss without 
apoptosis or necrosis as opposed to gonadal degeneration specifically presenting with 
evidence of apoptosis and necrosis.  Although incidences of these diagnoses occurred 
across all treatments and control, a higher percentage of individuals were affected in the 
higher treatments (Figure 2.4).  During normal testis development, all germ cells 
c. d.
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associated with a single spermatocyst mature at the same rate and the spermatocyst 
generally maintains a circular or ovoid shape.  Prochloraz treatment caused asynchronous 
development of germ cells within a spermatocyst and caused some spermatocysts to 
become irregular in shape (Figure 2.5); this occurred in a concentration-dependent 
manner.  The 180 µg/L treatment experienced increased incidences of interstitial fibrosis, 
interstitial cell hypertrophy and hyperplasia, and mononuclear cellular infiltrate 
indicating inflammatory and compensatory responses to prochloraz insult in the testis.  
The ovaries of prochloraz-treated females were generally unaffected except for a slight 
increase in occurrence of ovarian hypoplasia and ovarian germinal epithelial loss 
indicating interference of maturation (data not shown). 
 
Table 2.4.  Incidences of histopathological findings in control and prochloraz-exposed testis tissue of two month post-
metamorphosis male Xenopus laevis.  NR = not remarkable; T* = total. 
Chemical Dose (µg/L) 0.0 6.7 20 60 180 T* 
Number examined 36 25 24 24 25 134 
Missing tissue 1 0 0 2 0 3 
Gonadal degeneration apoptosis/necrosis        
NR 33 16 23 20 8 100 
Incidences 3 9 1 4 17 34 
Gonadal degeneration thinning/loss       
NR 33 21 22 13 3 92 
Incidences 3 4 2 11 12 42 
Testicular interstitial cell hypertrophy/hyperplasia       
NR 30 17 23 12 4 86 
Incidences 6 8 1 12 21 48 
Increased spermatogonia       
NR 34 24 22 21 19 120 
Incidences 2 1 2 3 6 14 
Interstitial fibrosis       
NR 27 13 17 18 3 78 
Incidences 9 12 7 6 22 56 
Asynchronous development within cysts       
NR 36 20 18 16 10 100 
Incidences 0 5 6 8 15 34 
Mononuclear cellular infiltrate       
NR 33 23 19 21 14 110 
Incidences 3 2 5 3 11 24 
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Figure 2.4.  Histology sections of control and prochloraz-treated testis tissues at two months post-
metamorphosis.  A) Control group male from prochloraz study, provided for reference, 10X. B) Prochloraz 
180 µg/L treatment group male, 10X. Gonadal degeneration thinning/ loss Grade 2. The germinal 
epithelium lining of numerous spermatic tubules is thin to absent (black arrows) with occasional exposure 
of the underlying basement membrane (red arrow). C) 180 µg/L treatment group male, 10X. Gonadal 
degeneration thinning/loss, Grade 4.  Diffusely, the germinal epithelium is missing or thin with frequent 
exposure of the underlying basement membranes (black arrows). 
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Figure 2.5. Histological section of asynchronous cyst development in testis tissue of prochloraz-treated 
male.  180µg/L study group male, 40X.  Asynchronous development within cysts, Grade 3. Individual 
spermatocysts (outlined in black) are irregular in shape and contain cell types of markedly differing 
maturity: spermatocytes (blue arrow), spermatids (red arrow) and spermatozoa (green arrow).  There are 
increased numbers of interstitial cells in the tubular interstices (red outline). 
 
Both male and female oviduct development were affected by prochloraz 
treatment.  Male oviduct regression was generally inhibited, and in some cases, oviducts 
matured to be characteristic of female oviducts at this stage of development (Table 2.5).  
Female oviducts exhibited accelerated development with prochloraz treatment.  The 
effects on the oviduct in both genders with prochloraz treatment is indicative of a 
feminizing effect similar to the feminization of secondary sex characteristics of male rats 
during perinatal prochloraz exposure (Noriega et al., 2005; Vingaard et al., 2005). 
 
Table 2.5.  Male and female oviduct stage distributions in control and prochloraz-exposed two month post-
metamorphosis Xenopus laevis.  T* = total.  
Chemical Dose (µg/L) 0.0 6.7 20 60 180 T* 
Number examined 37 25 24 26 25 137 
Male oviduct development       
Fibrous tag = 1 31 22 12 8 1 74 
Rudimentary = 2 6 2 10 15 23 56 
Partial = 3 0 1 2 3 1 7 
Female oviduct development       
Number examined 43 26 22 24 25 140 
Fibrous tag = 1 0 0 0 0 0 0 
Rudimentary = 2 19 0 2 1 3 25 
Partial = 3 24 26 20 23 22 115 
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Of the four genes chosen to evaluate the anti-androgenic effects of prochloraz, 
rflcii was the only transcript that showed any substantial changes across treatments.  The 
60 and 180 µg/L treatments were significantly different than control (p < 0.05, 
Jonckheere-Terpstra) and show 3 to >5-fold increases respectively (Figure 2.6A).  
Cyp17a1 was expressed at fairly high levels in all treatments and control relative to the 
other transcripts (Figure 2.6B) and the 180 µg/L treatment was statistically higher than 
control (p < 0.05, Jonckheere-Terpstra).  The remaining two transcripts, Sox9b and Dax-
1, did not change with prochloraz treatment (Figure 2.6C & D). 
 
 
Figure 2.6.  Gene expression levels in testis tissue of two month post-metamorphosis control and 
prochloraz-exposed Xenopus laevis.  Means ± SD (error bars) are expressed as copies mRNA per ng total 
RNA.  Asterisks (*) indicate treatments statistically different than control (p < 0.05, Jonckheere-Terpstra).    
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4. Discussion 
Prochloraz exposure throughout Xenopus laevis embryonic, larval and juvenile 
development resulted in a range of toxicological effects.  The observed hepatocellular 
degeneration, together with measured decreases in liver-somatic indices and 
intracytoplasmic inclusions in renal tubular cells are all indicative of metabolic toxicity in 
the 60 and 180 µg/L treatments.  The histologic appearance of the hepatic inclusions is 
suggestive of excess protein and ribo-nucleic acid aggregations presumably related to 
metabolism of prochloraz (Figure 2.2).  A study by Needham and Challis (1991) reported 
that one of the major prochloraz metabolites in rats was a glucuronide conjugate and high 
concentrations of prochloraz metabolites were found in liver tissue.  In the same study, 
high concentrations of prochloraz metabolites were also found in kidneys.  The similar 
appearance of hepatic and renal tubular cell inclusions in the current study is suggestive 
of metabolism, storage and excretion of prochloraz metabolites consistent with 
observations in rats (Needham and Challis, 1991).     
Histopathological evaluations of testes revealed degeneration of the germinal 
epithelium from prochloraz exposure mainly in the high test concentrations.  Although 
the severities of the degenerative effects were quite variable within the high treatments, 
one individual exhibited such severe thinning of the germinal epithelium that the tissue 
presented with many large voids throughout the sections (Figure 2.4).  Germinal 
epithelial thinning was generally accompanied by several other sub-acute testicular 
lesions (e.g. interstitial cell hyperplasia, interstitial fibrosis, asynchronous spermatocyst 
development) in the higher treatments.  This was in contrast to the lower treatments that, 
more often, presented with one or very few different lesions of minimal to mild severity.  
These chronic and sub-acute anti-androgenic effects of prochloraz are consistent with 
what has been reported in fathead minnows (Ankley et al., 2005) and rats (Blystone et 
al., 2007; Noriega et al., 2005).  Interestingly, the appearance of the testis sections 
suggest that normal morphogenesis was not initially inhibited by prochloraz, as the 
ultrastructure was generally completely formed.  More specifically, overall sizes of testes 
in the high prochloraz treatment were similar to control.  Also, testis cords and 
spermatocysts were formed and appeared to be progressing through spermatogenesis, 
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albeit atypically.  The degenerative process appears to occur either concurrently with 
unabated growth and formation of testis ultrastructure, or is allowed to take effect 
through some mechanism following the completion of testis morphogenesis.  The most 
plausible explanation for this is antagonism of androgen-mediated spermatogenesis that is 
initiated in the later phases of testis morphogenesis. 
Chapter 1 indicates that the transcriptional activity in the testis around completion 
of metamorphosis is primarily associated with morphogenesis including organization of 
the seminiferous tubules, differentiation of interstitial cells and production of connective 
tissue.  Once testis cords are formed, pre-spermatogenesis takes place during late larval 
development and the early juvenile period.  In two species of Rana, pre-spermatogenesis 
has been shown to occur at different points in the mating season independently of 
hormonal activity in interstitial tissue (reviewed by Ogielska, 2009).  Androgens become 
essential for the second meiotic division of germ cells, which convert secondary 
spermatocytes to spermatids.  Control testes in this study exhibited spermatocysts often 
containing spermatids and in some cases containing spermatozoa, indicating androgen-
mediated “active” spermatogenesis is taking place at two months post-metamorphosis.  
Therefore, critical levels of androgen are produced by steroidogenesis enzymes in the 
Leydig cells beginning at some point between the completion of metamorphosis and two 
months post-metamorphosis, presumably mediated by gonadotropins released by the 
pituitary.  The point at which androgens become necessary to support spermatogenesis is 
when the testis becomes sensitive to the anti-androgenic action of prochloraz, arresting 
meiosis and resulting in degeneration of the already formed germinal epithelium. 
Cyp17a1 gene expression levels in testes (Figure 2.6B) also support the proposal 
that steroidogenesis is active and prochloraz treatment may cause compensatory 
induction of the enzyme’s transcript.  This was not a strong response, as there appears to 
be high levels of the Cyp17a1 transcript already present in all treatments and controls.  
Therefore, the weak response exhibited by this gene could be due to high levels of 
CYP17 already present.  Also, there were spermatids and spermatozoa in testes of the 
animals in the 180 µg/L treatment indicating that prochloraz was not capable of 
completely arresting testosterone production by CYP17 inhibition at this level of 
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exposure.  In a study by Ankley et al. (2009), male fathead minnows exhibited 
significantly reduced circulating testosterone levels with a corresponding significant 
increase in testis Cyp17 mRNA.  While it is acknowledged the fish were exposed to 300 
µg/L prochloraz for only eight days, the response is consistent with the apparent response 
seen here.  It is possible that up-regulation of testis Cyp17 is an indicator of impaired 
testosterone production across species.  However, the weak, and perhaps questionable, 
response seen in this study indicates its lack of usefulness as a biomarker in this 
particular system. 
In addition to its ability to impair testosterone production, prochloraz has been 
shown to interfere with the androgen receptor (Vinggaard et al., 2002).  Androgen 
receptor is highly expressed in the testis and to a much lesser degree in many peripheral 
tissues for regulation of secondary sexual maturation (Sassoon and Kelley, 1986; Sassoon 
et al., 1987; Tobias et al., 1991; Variale and Serino, 1994; Tobias and Kelley, 1995).  An 
attempt was made in the current study to assess androgen/androgen receptor signaling in 
the testis using a series of gene transcript expression profiles.  Rflcii (relaxin-like factor) 
in Xenopus is orthologous to the mammalian Insl3 (insulin-like 3) Leydig cell-specific 
growth factor peptide hormone.  Insl3 expression in mammalian Leydig cells is regulated 
by testosterone in an androgen receptor-dependent manner (Laguë and Tremblay, 2008).  
In the same study, Laguë and Tremblay reported antagonism of testosterone-mediated 
Insl3 expression by anti-androgen mono-(2ethylhexyl) phthalate.  Therefore, I 
hypothesized that Rflcii in Xenopus laevis would be down-regulated as a result of 
disruption of testosterone production and androgen/androgen receptor signaling.  
However, the results were the opposite of this hypothesis, with significant induction of 
Rflcii seen after exposure to 60 or 180 µg/L prochloraz (Figure 2.6A).  To understand 
this unexpected relationship, it is necessary to understand the putative role that this 
relaxin-like factor plays in the testis and the mechanisms by which it may be regulated. 
Insl3 has been well-characterized in mammalian reproductive development; 
however, this peptide has only recently been considered in teleosts and is essentially 
uncharacterized in amphibians (Bathgate et al., 2013; Good-Avila et al., 2009).  The 
relaxin family of genes within and between species shares very little sequence similarity, 
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but the resulting peptides share structural similarity with insulin and confer similar 
functionality (Wilkinson et al., 2005).  Insl3 in mammals during early reproductive 
development is highly expressed in fetal Leydig cells and is responsible for testis decent 
by acting on the gubernaculum (Zimmermann et al., 1999; Nef and Parada, 1999).  
Prevention of germ cell apoptosis by paracrine signaling has also been a suggested role of 
INSL3 in the adult rat testis (Anand-Ivell et al., 2006; Kawanamura et al., 2004).  
Protection of male germ cells by RFLCII (INSL3) seems more plausible in Xenopus as 
gonads in amphibians do not descend or migrate from the location of the original anlage.  
Further support of the protective role of Xenopus RFLCII is the response of its expression 
levels elicited by exposure to higher concentrations of prochloraz, together with the 
observed pathologies related to germinal epithelial degeneration.  Induction of this gene 
in the current study appears to be an adaptive response, and in this case may act as an 
exceptional biomarker of impaired testis function. 
The question remains as to how this gene is regulated in Xenopus if not in part by 
androgen/androgen receptor signaling as in mammalian Insl3.  Without performing an 
analysis on the Xenopus rflcii promoter, alternate mechanisms of regulation demonstrated 
in mammalian models is all that is available for speculation.  As such, SF-1-mediated 
transcriptional regulation of the relaxin-like factor promoter has been well-documented 
(Koskimies, et al., 2002; Zimmerman et al., 1998; Sadeghian et al., 2005; Robert et al., 
2006; Tremblay and Robert, 2005).  Relevant to the current study, DAX-1 has been 
shown to antagonize SF-1 regulation of the murine relaxin-like factor promoter 
(Koskimies et al., 2002).  Dax-1 expression in the testis across all treatments and control 
is very low in comparison to expression levels of all three other genes and is not 
influenced by prochloraz exposure (Figure 2.6D).  This supports the possibility that 
absence of DAX-1 allows uninhibited positive regulation of rflcii by SF-1.  However, 
Leydig cell-specific Sf-1 null mice were still able to produce low levels of Insl3 and testis 
descent was not affected to the degree it was affected in the Insl3 knockout mouse model 
(Jeyasuria et al., 2004).  This means mammalian Insl3 is regulated by multiple alternative 
mechanisms. 
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NR4A1 is an orphan nuclear receptor and transcription factor expressed in Leydig 
cells and has been shown to be rapidly induced in response to LH and cAMP analogs 
(Tremblay and Robert, 2005; Martin and Tremblay, 2005; Song et al., 2001).  Tremblay 
and Robert (2005) demonstrated through transfection assays that NR4A1 was a much 
stronger activator of the Insl3 promoter than SF-1.  The observation that androgen-
mediated “active” spermatogenesis is taking place (explained earlier) in the current study 
supports the notion of LH-mediated activation of steroidogenesis in the Leydig cells.  
There is evidence from receptor expression profiles in different mammalian tissues that 
relaxin-like factors communicate with the brain through circulatory feedback (Bathgate et 
al., 2013).  This supports a potential adaptive signaling response to the gonadotropic cells 
in the hypothalamus and pituitary possibly playing a role in modulation of circulating 
gonadotropins.  
A more local explanation could involve Insl3-mediated paracrine regulation of 
androgen production through bone morphogenic proteins (BMP), as was demonstrated in 
ovarian androgen production (Glister et al., 2013).  Glister et al. (2013) showed that 
knockdown of INSL3 or its receptor, RXFP2, in cultured bovine theca cells resulted in 
77% and 81% reductions of Cyp17 mRNA respectively, along with reduced 
androstenedione secretion.  While it is acknowledged this work was done with bovine 
thecal cells, they are the Leydig cell equivalent steroidogenic cell in the ovary that 
exhibits many of the same regulatory mechanisms of steroidogenic genes.  Also, the gene 
array study presented in Chapter 1 showed that bmp1 was expressed at a similar level as 
rflcii in the testis and was highly testis-enriched.  The expression profiles of rflcii and 
Cyp17a1 in the current study support the possibility that RFLCII may locally regulate 
androgen production by regulating Cyp17 expression.  Further targeted experiments to 
test these relationships are necessary to fully understand the mechanism by which the 
anti-androgen prochloraz causes such a robust positive response in rflcii expression. 
Dax-1 was also chosen to assess the androgen/androgen receptor regulatory 
network in the current study and did not respond to prochloraz treatment (Figure 2.6D).  
Dax-1 has been shown to be developmentally regulated in different tissues and exhibits 
particularly dynamic functionality (Achermann et al., 2001b; Jadhav, et al., 2011; Tamai 
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et al., 1996).  Its testis-biased expression in Xenopus tropicalis during gonad 
differentiation (Chapter 1) is likely due to its suppressive effect on SF-1-mediated Cyp19 
aromatase expression (Guarates et al., 2003; Wang et al., 2001).  This ultimately inhibits 
production of β-estradiol during the time the testis is most susceptible to estrogen-
induced dysgenesis or sex reversal (Villalpando and Merchant-Larios, 1990).  Shortly 
after the completion of metamorphosis in Anurans, the hypothalamus and pituitary 
become able to secrete gonadotropins (reviewed by Ogielska, 2009c).  Presumably, 
release of FSH and LH and subsequent cAMP production in Sertoli and Leydig cells 
down-regulate Dax-1 in the testis when steroid hormone production becomes necessary 
for spermatogenesis (Song et al., 2004; Tamai et al., 1996).  With steroidogenesis 
activated through gonadotropin hormones and SF-1, DAX-1 interference with SF-1 
appears to no longer be necessary in the testis at two months post metamorphosis.  This is 
consistent with the low expression levels in the current study and makes Dax-1 only a 
potential indicator of active gonadotropin signaling.  However, this would require further 
targeted experimentation. 
Sox9b was also unaffected by prochloraz treatment (Figure 2.6C).  This suggests 
that Sox9b is not regulated by androgen/androgen receptor, at least during this period of 
development.  Interestingly, the Sox9b expression profile across treatments and control is 
very similar to the Dax-1 expression profile, but Sox9b expression is approximately 10-
fold higher.  This apparent relationship supports their close proximity within a regulatory 
network.  As discussed earlier, they both have been shown to interact with SF-1, but play 
opposite roles.  The putative interaction of SOX9 with SF-1 upregulates AMH, which 
mediates regression of the oviducts in male Xenopus.  In the current study, oviduct 
regression was attenuated in prochloraz-treated males and oviduct maturation was 
accelerated in prochloraz-treated females (Table 2.5).  Regardless of the direct molecular 
mechanism triggering oviduct regression or maturation, its fate is highly sensitive to 
exogenous androgenic and estrogenic substances respectively (USEPA, 2013; Porter et 
al., 2011).  Therefore, it appears androgen is necessary, but may not be sufficient, for 
oviduct regression.  In females, it appears as though constitutive levels of androgen slow 
oviduct maturation and reduction of androgen levels by prochloraz allows unabated 
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maturation.  In this case, Sox9b is not a good indicator of this androgen-mediated 
process. 
 
5. Conclusion 
Overall, the anti-androgenic effects of prochloraz exposure were present in 
Xenopus laevis and consistent with the anti-androgenic effects observed in other species.  
The onset of testis degeneration coinciding with the androgen-mediated phase of 
spermatogenesis emphasizes the higher probability of adverse reproductive effects with 
exposure during the juvenile period of development, as opposed to the periods of 
embryonic or larval development.  This supports the idea that the testes did not 
experience “dysgenesis.”  Rather, they experienced impaired spermatogenesis and 
resulted in testicular degeneration.  Prochloraz is readily metabolized and the likelihood 
of constant environmental exposure at the levels tested here is low, especially because 
most amphibians transition to terrestrial life after completing metamorphosis.  However, 
the need for concern arises during the mating season when acute aquatic exposure to 
prochloraz could interfere with spermatogenesis, even though the acute effects are likely 
reversible upon depuration.  This critical window for seasonal breeders is clearly the 
highest risk time period for prochloraz exposure.  Exposure to prochloraz (or anti-
androgens) around breeding times must be given a higher level of consideration than 
other life stages for amphibian ecological risk assessment.   
While the gene expression biomarkers did not provide a wealth of information 
regarding the chemical mode of action as intended, their expression profiles and 
regulation in other species stimulated valuable speculative discussion and generated a 
series of testable hypotheses.  Subsequent investigations to elucidate rflcii regulation and 
mechanisms of action in amphibians could solidify its utility as a biomarker of Leydig 
cell function, gonadotropin signaling, and steroidogenesis.  This work establishes this 
gene as an important factor in amphibian reproductive development.  Further 
characterization of this protein may discover that it is essential for amphibian 
reproduction. 
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Chapter 3. Conclusion and future directions 
 
 The approach taken herein to develop expression-based biomarkers of impaired 
gonad function involved many complicated techniques.  The microarray time-course in 
testis and ovary tissue lent numerous layers of complexity and decision making regarding 
normalization strategies, statistical comparisons, multiple comparison corrections, fold-
change cutoffs, and biological references.  Due to the status of Xenopus (or amphibian) 
molecular bioinformatic resources, pathway/network analyses were difficult to generate, 
and even more difficult to interpret.  Therefore, it was decided to pursue the well-
developed mammalian bioinformatic resources by translating as many transcripts as 
possible into human orthologs.  This required computer programming skills to automate 
UniGene database navigation and acquisition of human accession numbers for thousands 
of Xenopus tropicalis array transcripts.  Gene lists could then be recognized by Ingenuity 
Pathway Analysis software that allowed functional analyses and direct access to 
references providing precedent for molecular interactions.  This was the basis from which 
genes were chosen to evaluate the particular anti-androgenic mode of action of 
prochloraz.  The foundation of information provided by the gene array study lends well 
toward biomarker development and elucidation of other modes of action in ovary tissue 
also. 
 Following the gene array study and selection of candidate biomarkers, 
bioinformatic analyses were employed to identify gene homologs in Xenopus laevis using 
the EST database.  Subsequently, primers and probes were designed for development of 
quantitative PCR assays for each of the four genes.  Results from the gene expression 
analyses in testis tissues exposed to prochloraz were generally not consistent with what 
was expected, but all had plausible explanations for their behavior.  In the current study 
design, rflcii appears to be predictive of impaired spermatogenesis.  However, further 
experimentation is necessary in order to confirm its predictive capabilities with different 
anti-androgens in Xenopus, and to assess its predictive capabilities across species.  
Understanding the mechanism by which it is regulated would be the first step.  This could 
be accomplished by culturing juvenile testes ex vivo and exposing the tissue to various 
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compounds or hormones and measuring the resulting gene expression response.  For 
instance, addition of LH would indicate whether this gene is regulated via hypothalamic-
pituitary gonadotropins through cAMP signaling and possibly a NR4A1 ortholog.  
Locating this protein’s receptor with fluorescence in situ hybridization would help to 
understand its target cell population. Purifying the RFLCII protein and generating 
antibodies would allow development of an ELISA to measure secretion of this factor into 
the culture media to understand the relationship between gene expression and de novo 
protein synthesis.  This could lead to an assay capable of measuring blood levels of this 
protein in vivo potentially indicating Leydig cell function.  Relaxin-like factors could be a 
key indicator of Leydig cell function even across species, opening up the possibility of 
making field assessments on high-risk populations. 
 The goal of modern day ecotoxicology is to link a molecular initiating event to an 
adverse organismal outcome by using the least amount of animal and financial resources 
possible.  Understanding the molecular basis for reproductive differentiation, 
manifestations of gonad pathologies and gene regulation will expedite the understanding 
of molecular initiating events.  Also understanding species differences in these molecular 
programs will provide a spectrum of species susceptibilities, allowing focused efforts 
toward preservation of higher-risk populations.  The work presented in this thesis 
provides direction toward attaining this goal. 
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#################################################################
#################
"""Creates a dictionary of UniGene IDs as keys and 
corresponding human orthologues as values.  Need UniGene 
Xx.data file for species of interest (
ftp://ftp.ncbi.nih.gov/repository/UniGene/)"""
from Bio import UniGene
handle = open("C:\Python27\Doc\Str.data")
ugparser = UniGene.parse(handle)
UG_Dict = {}
for record in ugparser:
for protsim in record.protsim:
if protsim.org=="9606":
UG_Dict[record.ID]=record.ID, protsim.protid,
protsim.pct, protsim.aln
print record.ID, "has human orthologue"
handle.close
#################################################################
#################
""" Writes the UniGene dictionary to .csv file so it can be 
built faster than rebuilding from database file."""
import csv
with open('UG_Dict.csv', 'wb') as f:
writer = csv.writer(f)
for item in UG_Dict:
writer.writerow(UG_Dict[item])
f.close()
#################################################################
#################
"""Creates a dictionary of the annotation file so accessions 
can be called and human orthologues can be appended to each 
probe annotation"""
#Call Representative Public ID with Annot_Dict[Probe Set ID][8]
#Archival UniGene Cluster = [9]
#UniGene ID = [10]
#Gene Symbol = [14]
#Ensembl = [17]
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#Entrez Gene = [18]
#SwissProt = [19]
#Annotation transcript cluster = [38]
#Updated UniGene ID = [41]
import csv
Annot_Dict = {}
with open('C:\Python27\Doc\X_tropicalis.na32.annot.csv', 'rb')
as f:
reader = csv.reader(f, delimiter=',', quotechar='"')
for row in reader:
if not '#' in row[0]:
Annot_Dict[row[0]] = row[0:]
f.close()
#################################################################
#################
"""Updates UniGene IDs using Representative Public ID and 
appends to each probe annotation.  Database needed: Str.retired 
(UniGene) or other species of interest"""
update_UniGene_ID = "C:\Python27\Doc\Str.retired"
UGcount = 0
UGnone_count = 0
incompatible = 0
for item in Annot_Dict:
if 'AFFX' in Annot_Dict[item][8]:
incompatible +=1
Annot_Dict[item].append('---')
UGnone_count +=1
print Annot_Dict[item][8], "incompatible ID.", ID
elif 'ENSXETT' in Annot_Dict[item][8]:
ID = ""
if '(' in Annot_Dict[item][38]:
for s in Annot_Dict[item][38]:
if s != '(':
ID +=s
else:
break
else:
for s in Annot_Dict[item][38]:
if s != ',':
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ID +=s
else:
break
if 'ENSXETT' in ID:
incompatible +=1
Annot_Dict[item].append('---')
UGnone_count +=1
print Annot_Dict[item][8], "incompatible ID.", ID
else:
infile = open(update_UniGene_ID)
for line in infile.xreadlines():
flag = 0
if ID in line:
fields = line.split()
new_UGID = fields[1]
Annot_Dict[item].append(new_UGID)
flag = 1
UGcount +=1
break
if flag == 0:
Annot_Dict[item].append('---')
UGnone_count +=1
print ID
print UGcount, "updated UniGene IDs and",
UGnone_count, "unrecognized IDs."
infile.close()
elif 'jgi|' in Annot_Dict[item][8]:
ID = ""
if '(' in Annot_Dict[item][38]:
for s in Annot_Dict[item][38]:
if s != '(':
ID +=s
else:
break
else:
for s in Annot_Dict[item][38]:
if s != ',':
ID +=s
else:
break
if 'jgi|' in ID:
incompatible +=1
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Annot_Dict[item].append('---')
UGnone_count +=1
print Annot_Dict[item][8], "incompatible ID.", ID
else:
infile = open(update_UniGene_ID)
for line in infile.xreadlines():
flag = 0
if ID in line:
fields = line.split()
new_UGID = fields[1]
Annot_Dict[item].append(new_UGID)
flag = 1
UGcount +=1
break
if flag == 0:
Annot_Dict[item].append('---')
UGnone_count +=1
print ID
print UGcount, "updated UniGene IDs and",
UGnone_count, "unrecognized IDs."
infile.close()
elif 'RPTR' in Annot_Dict[item][8]:
ID = ""
if '(' in Annot_Dict[item][38]:
for s in Annot_Dict[item][38]:
if s != '(':
ID +=s
else:
break
else:
for s in Annot_Dict[item][38]:
if s != ',':
ID +=s
else:
break
if 'RPTR' in ID:
incompatible +=1
Annot_Dict[item].append('---')
UGnone_count +=1
print Annot_Dict[item][8], "incompatible ID.", ID
else:
infile = open(update_UniGene_ID)
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for line in infile.xreadlines():
flag = 0
if ID in line:
fields = line.split()
new_UGID = fields[1]
Annot_Dict[item].append(new_UGID)
flag = 1
UGcount +=1
break
if flag == 0:
Annot_Dict[item].append('---')
UGnone_count +=1
print ID
print UGcount, "updated UniGene IDs and",
UGnone_count, "unrecognized IDs."
infile.close()
else:
if '.' in Annot_Dict[item][8]:
ID = ""
for s in Annot_Dict[item][8]:
if s != '.':
ID +=s
elif s == '.':
break
else:
ID = Annot_Dict[item][8]
infile = open(update_UniGene_ID)
for line in infile.xreadlines():
flag = 0
if ID in line:
fields = line.split()
new_UGID = fields[1]
Annot_Dict[item].append(new_UGID)
flag = 1
UGcount +=1
break
if flag == 0:
Annot_Dict[item].append('---')
UGnone_count +=1
print ID
print UGcount, "updated UniGene IDs and", UGnone_count,
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"unrecognized IDs."
infile.close()
if Annot_Dict[item][41]=='---':
ID = ""
if '(' in Annot_Dict[item][38]:
for s in Annot_Dict[item][38]:
if s != '(':
ID +=s
else:
break
else:
for s in Annot_Dict[item][38]:
if s != ',':
ID +=s
else:
break
if ID != Annot_Dict[item][8]:
infile = open(update_UniGene_ID)
for line in infile.xreadlines():
flag = 0
if ID in line:
fields = line.split()
new_UGID = fields[1]
del Annot_Dict[item][41]
Annot_Dict[item].append(new_UGID)
flag = 1
UGnone_count -=1
UGcount +=1
print "UGID found with annotation 
transcript cluster"
break
infile.close()
print ID
print UGcount, "updated UniGene IDs and",
UGnone_count, "unrecognized IDs."
Annot_Dict['Probe Set ID'][41]='Updated UniGene ID'
print UGcount, "updated UniGene IDs,", UGnone_count,
"unrecognized IDs, and", incompatible, "incompatible IDs."
#################################################################
#################
"""Writes updated annotation dictionary to .csv file so 
dictionary can be re-created faster without having to run 
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UniGene update over again."""
import csv
with open('new_annot_w_new_UGID_update_method.csv', 'wb') as f:
writer = csv.writer(f, delimiter=',', quotechar='"')
writer.writerow(Annot_Dict['Probe Set ID'])
for item in Annot_Dict:
writer.writerow(Annot_Dict[item])
f.close()
#################################################################
#################
"""Rebuilds annotation dictionary and UniGene dictionary using 
.csv files rather than from databases."""
import csv
Annot_Dict = {}
with open('new_annot_w_new_UGID_update_method.csv', 'rb') as f:
reader = csv.reader(f, delimiter=',', quotechar='"')
for row in reader:
Annot_Dict[row[0]] = row[0:]
f.close()
print "Annot_Dict import successful."
import csv
UG_Dict = {}
with open('UG_Dict.csv', 'rb') as f:
reader = csv.reader(f, delimiter=',', quotechar='"')
for row in reader:
UG_Dict[row[0]] = row[0:]
f.close()
print "UG_Dict import successful."
#################################################################
#################
"""Uses annotation dictionary for UniGene IDs and searches 
UniGene dictionary for human orthologues which are appended to 
probe annotation if available."""
count = 0
none_count = 0
Annot_Dict['Probe Set ID'].append('Human Ortholog Accession1')
Annot_Dict['Probe Set ID'].append('Hs_Orth1 PCT')
Annot_Dict['Probe Set ID'].append('Hs_Orth1 ALN')
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Annot_Dict['Probe Set ID'].append('Human Ortholog Accession2')
Annot_Dict['Probe Set ID'].append('Hs_Orth2 PCT')
Annot_Dict['Probe Set ID'].append('Hs_Orth2 ALN')
Annot_Dict['Probe Set ID'].append('Human Ortholog Accession3')
Annot_Dict['Probe Set ID'].append('Hs_Orth3 PCT')
Annot_Dict['Probe Set ID'].append('Hs_Orth3 ALN')
for i in Annot_Dict:
if Annot_Dict[i][41]==Annot_Dict[i][10]==Annot_Dict[i][9]:
flag = 0
ID = Annot_Dict[i][41]
print ID
if ID == '---':
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
none_count +=1
print "No UniGene ID."
else:
for j in UG_Dict:
if ID==UG_Dict[j][0]:
Annot_Dict[i].append(UG_Dict[j][1])
Annot_Dict[i].append(UG_Dict[j][2])
Annot_Dict[i].append(UG_Dict[j][3])
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
flag = 1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
break
if flag==0:
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Appendix A 80
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
none_count +=1
print "No Record!"
elif Annot_Dict[i][41]==Annot_Dict[i][9]:
flag = 0
ID1 = Annot_Dict[i][41]
ID2 = Annot_Dict[i][10]
prot1 = 0
prot2 = 0
for j in UG_Dict:
if ID1==UG_Dict[j][0]:
protID1 = UG_Dict[j][1]
pct1 = float(UG_Dict[j][2])
aln1 = float(UG_Dict[j][3])
score1 = pct1 * aln1
flag +=1
prot1 = 1
if ID2==UG_Dict[j][0]:
protID2 = UG_Dict[j][1]
pct2 = float(UG_Dict[j][2])
aln2 = float(UG_Dict[j][3])
score2 = pct2 * aln2
flag +=1
prot2 = 1
if flag==2:
break
if flag==2:
if protID1==protID2:
Annot_Dict[i].append(protID1)
if score1>score2:
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
else:
if score1>score2:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
if flag==1:
if prot1==1:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
if flag==0:
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
none_count +=1
print "Two IDs and no Record!", ID1, ID2
elif Annot_Dict[i][41]==Annot_Dict[i][10]:
flag = 0
ID1 = Annot_Dict[i][41]
ID2 = Annot_Dict[i][9]
prot1 = 0
prot2 = 0
for j in UG_Dict:
if ID1==UG_Dict[j][0]:
protID1 = UG_Dict[j][1]
pct1 = float(UG_Dict[j][2])
aln1 = float(UG_Dict[j][3])
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score1 = pct1 * aln1
flag +=1
prot1 = 1
if ID2==UG_Dict[j][0]:
protID2 = UG_Dict[j][1]
pct2 = float(UG_Dict[j][2])
aln2 = float(UG_Dict[j][3])
score2 = pct2 * aln2
flag +=1
prot2 = 1
if flag==2:
break
if flag==2:
if protID1==protID2:
Annot_Dict[i].append(protID1)
if score1>score2:
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
else:
if score1>score2:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
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Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
if flag==1:
if prot1==1:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
if flag==0:
Annot_Dict[i].append('---')
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
none_count +=1
elif Annot_Dict[i][10]==Annot_Dict[i][9]:
flag = 0
ID1 = Annot_Dict[i][41]
ID2 = Annot_Dict[i][10]
prot1 = 0
prot2 = 0
for j in UG_Dict:
if ID1==UG_Dict[j][0]:
protID1 = UG_Dict[j][1]
pct1 = float(UG_Dict[j][2])
aln1 = float(UG_Dict[j][3])
score1 = pct1 * aln1
flag +=1
prot1 = 1
if ID2==UG_Dict[j][0]:
protID2 = UG_Dict[j][1]
pct2 = float(UG_Dict[j][2])
aln2 = float(UG_Dict[j][3])
score2 = pct2 * aln2
flag +=1
prot2 = 1
if flag==2:
break
if flag==2:
if protID1==protID2:
Annot_Dict[i].append(protID1)
if score1>score2:
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
else:
if score1>score2:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
if flag==1:
if prot1==1:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
if flag==0:
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
none_count +=1
else:
ID1 = Annot_Dict[i][41]
ID2 = Annot_Dict[i][10]
ID3 = Annot_Dict[i][9]
flag = 0
prot1 = 0
prot2 = 0
prot3 = 0
for j in UG_Dict:
if ID1==UG_Dict[j][0]:
protID1 = UG_Dict[j][1]
pct1 = float(UG_Dict[j][2])
aln1 = float(UG_Dict[j][3])
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score1 = pct1 * aln1
prot1 = 1
flag += 1
if ID2==UG_Dict[j][0]:
protID2 = UG_Dict[j][1]
pct2 = float(UG_Dict[j][2])
aln2 = float(UG_Dict[j][3])
score2 = pct2 * aln2
prot2 = 1
flag += 1
if ID3==UG_Dict[j][0]:
protID3 = UG_Dict[j][1]
pct3 = float(UG_Dict[j][2])
aln3 = float(UG_Dict[j][3])
score3 = pct3 * aln3
prot3 = 1
flag += 1
if flag==0:
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
none_count +=1
elif flag==1:
if prot1==1:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
elif prot2==1:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
elif flag==2:
if prot1==1 and prot2==1:
if protID1==protID2:
Annot_Dict[i].append(protID1)
if score1>score2:
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
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if score1>score2:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
elif prot1==1 and prot3==1:
if protID1==protID3:
Annot_Dict[i].append(protID1)
if score1>score3:
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
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Annot_Dict[i].append('---')
else:
if score1>score3:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
elif prot2==1 and prot3==1:
if protID2==protID3:
Annot_Dict[i].append(protID2)
if score2>score3:
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
if score2>score3:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
elif flag==3:
if protID1==protID2==protID3:
Annot_Dict[i].append(protID1)
if score1>score2 and score1>score3:
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
elif score2>score1 and score2>score3:
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
elif protID1==protID2:
if score1>score2:
newprot = protID1
newpct = pct1
newaln = aln1
newscore = score1
else:
newprot = protID2
newpct = pct2
newaln = aln2
newscore = score2
if newscore>score3:
Annot_Dict[i].append(newprot)
Annot_Dict[i].append(newpct)
Annot_Dict[i].append(newaln)
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append(newprot)
Annot_Dict[i].append(newpct)
Annot_Dict[i].append(newaln)
Annot_Dict[i].append('---')
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Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
elif protID1==protID3:
if score1>score3:
newprot = protID1
newpct = pct1
newaln = aln1
newscore = score1
else:
newprot = protID3
newpct = pct3
newaln = aln3
newscore = score3
if newscore>score2:
Annot_Dict[i].append(newprot)
Annot_Dict[i].append(newpct)
Annot_Dict[i].append(newaln)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(newprot)
Annot_Dict[i].append(newpct)
Annot_Dict[i].append(newaln)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
elif protID2==protID3:
if score2>score3:
newprot = protID2
newpct = pct2
newaln = aln2
newscore = score2
else:
newprot = protID3
newpct = pct3
newaln = aln3
Appendix A 95
newscore = score3
if newscore>score1:
Annot_Dict[i].append(newprot)
Annot_Dict[i].append(newpct)
Annot_Dict[i].append(newaln)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(newprot)
Annot_Dict[i].append(newpct)
Annot_Dict[i].append(newaln)
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
Annot_Dict[i].append('---')
else:
if score1>score2 and score1>score3:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
if score2>score3:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
else:
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
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elif score2>score1 and score2>score3:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
if score1>score3:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
else:
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
else:
Annot_Dict[i].append(protID3)
Annot_Dict[i].append(pct3)
Annot_Dict[i].append(aln3)
if score1>score2:
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
else:
Annot_Dict[i].append(protID2)
Annot_Dict[i].append(pct2)
Annot_Dict[i].append(aln2)
Annot_Dict[i].append(protID1)
Annot_Dict[i].append(pct1)
Annot_Dict[i].append(aln1)
count +=1
print count, "Human orthologues found and",
none_count, "probes without ortholog."
print "Done"
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print count, "Human orthologues found and", none_count, "probes 
without ortholog."
#################################################################
#################
"""Writes annotation file to .csv containing human ortholog 
accessions and corresponding alignment data"""
import csv
with open('new_annot3.csv', 'wb') as f:
writer = csv.writer(f)
writer.writerow(Annot_Dict['Probe Set ID'])
for item in Annot_Dict:
writer.writerow(Annot_Dict[item])
f.close()
Appendix A 98
99 
 
 
 
 
 
 
 
 
 
Appendix B: Transcript IDs and functional information 
corresponding to Figure 2 heatmap. 
 
Probe ID Human Accession Cluster NF58 NF66 1WPM 2WPM
Gene Symbol 
(Human) Entrez Human Gene Name Mammalian Function
Str.24079.1.A1_at NP_060439.2 Ovary-A 1 1 14 40 (iws1) IWS1 homolog (S. cerevisiae) Cancer-related
Str.10336.1.S1_at NP_653277.2 Ovary-A 1 2 17 34 tmed6 transmembrane emp24 protein transport domain containing 6
Str.50399.1.S1_at NP_002745.1 Ovary-A 1 2 13 16 mapk13 mitogen-activated protein kinase 13 Cancer-related, cell proliferation
Str.1727.3.A2_a_at NP_031397.1 Ovary-A 1 1 65 47 brdt (brd3) bromodomain containing 3
Str.31845.1.S1_at NP_000896.1 Ovary-A 1 4 25 57 npy neuropeptide Y Vascularization, secretion of hormone, fertility
Str.7244.1.S1_at NP_001008779.1 Ovary-A 1 5 29 57 (spdya) speedy homolog A (Xenopus laevis) Oocyte maturation
Str.32211.1.A1_at NP_001096637.1 Ovary-A 1 7 30 26 (zglp1) zinc finger, GATA-like protein 1 Gonadogenesis, gametogenesis, oogenesis, ovary development
Str.34301.2.S1_at NP_115508.2 Ovary-A 1 14 29 6 (hormad1) HORMA domain containing 1 Gonadogenesis, gametogenesis, meiosis, fertility (male)
Str.1727.3.A1_at NP_001717.2 Ovary-A 1 3 13 8 brdt bromodomain, testis-specific Gonadogenesis, chromatin remodeling (male)
Str.27519.1.S1_at NP_003185.1 Ovary-A 1 4 9 11 tbpl2 (tbp) TATA box binding protein Transcription, embryonic development
Str.34382.1.A1_at NP_751898.1 Ovary-A 1 4 15 8 msh5 mutS homolog 5 (E. coli) Gonadogenesis, gametogenesis, meiosis, fertility
Str.32425.1.A1_at NP_570140.1 Ovary-A 1 3 16 9 (syce1) synaptonemal complex central element protein 1 Meiosis
Str.33708.1.A1_at NP_001128320.1 Ovary-A 1 3 17 9 (ccdc152) coiled-coil domain containing 152
StrAffx.106.1.S1_s_at NP_694999.3 Ovary-A 2 4 13 12 mamdc2 MAM domain containing 2
Str.38722.1.S1_at NP_872365.1 Ovary-A 1 6 23 10 tmprss12 transmembrane (C-terminal) protease, serine 12 Cancer-related
Str.33833.1.A1_at NP_079335.2 Ovary-A 1 2 10 7 (ccdc170) coiled-coil domain containing 170 Cancer-related
Str.21686.1.S1_at NP_000726.1 Ovary-A 1 3 9 9 (cga) glycoprotein hormones, alpha polypeptide Gonadogenesis, morphology of ovary, quantity of hormone, fertility
Str.37820.1.S1_at NP_001130042.1 Ovary-A 2 3 7 6 (fam47e) family with sequence similarity 47, member E
Str.31912.1.A1_at NP_689820.2 Ovary-A 2 4 7 6 (c1orf177) chromosome 1 open reading frame 177
Str.38593.1.S1_at NP_001026918.2 Ovary-A 1 2 9 5 (c12orf40) chromosome 12 open reading frame 40
Str.33738.1.A1_at NP_001017975.3 Ovary-A 2 4 11 7 hfm1 HFM1, ATP-dependent DNA helicase homolog (S. cerevisiae) Cancer-related
Str.34278.1.A1_at NP_001003811.1 Ovary-A 1 5 11 7 (tex11) testis expressed 11 Gonadogenesis, gametogenesis, meiosis, fertility (male)
Str.34311.2.A1_at NP_001008777.2 Ovary-A 2 4 9 6 fbxo47 F-box protein 47 Cancer-related
Str.34301.3.A1_x_at NP_115508.2 Ovary-A 1 8 13 6 (hormad1) HORMA domain containing 1 Gonadogenesis, gametogenesis, meiosis, fertility (male)
Str.34301.1.S1_a_at NP_115508.2 Ovary-A 1 8 16 8 (hormad1) HORMA domain containing 1 Gonadogenesis, gametogenesis, meiosis, fertility (male)
Str.34301.1.S1_at NP_115508.2 Ovary-A 1 11 18 7 (hormad1) HORMA domain containing 1 Gonadogenesis, gametogenesis, meiosis, fertility (male)
Str.42327.1.A1_at NP_001099048.1 Ovary-A 1 7 19 11 (syce2) synaptonemal complex central element protein 2 DNA recombination, synapsis, meiosis
Str.49258.1.A1_at NP_008999.2 Ovary-A 2 13 27 9 (dmc1)
DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous 
recombination (yeast) Gonadogenesis, gametogenesis, oogenesis, meiosis, fertility
Str.51692.1.S1_at NP_444505.1 Ovary-A 2 5 3 7 (rplp0) ribosomal protein, large, P0 Cancer-related
Str.20782.1.S1_a_at NP_060369.3 Ovary-A 1 2 4 5 tesc tescalcin Neurological disease, Na+ homeostasis
Str.32672.1.A1_at NP_001138400.1 Ovary-A 1 2 4 5 (nkiras2) NFKB inhibitor interacting Ras-like 2 Cancer-related
Str.30634.1.A1_at NP_009131.2 Ovary-A 1 2 4 5 (akap13) A kinase (PRKA) anchor protein 13 Cancer-related, decondensation of chromatin
Str.15244.2.S1_a_at NP_079197.3 Ovary-A 2 2 4 5 pof1b premature ovarian failure, 1B Cancer-related, premature ovarian failure
Str.8393.1.S1_at NP_001118228.1 Ovary-A 2 2 3 5 pabpc1l poly(A) binding protein, cytoplasmic 1-like Gonadogenesis, gametogenesis, oogenesis, meiosis, fertility
Str.52229.1.S1_at NP_000976.1 Ovary-A 3 3 4 5 (rpl17) ribosomal protein L17 Cancer-related
Str.26910.1.S1_at NP_001164666.1 Ovary-A 3 3 4 6 elavl2 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) Cancer-related
Str.19885.1.S1_at NP_006863.2 Ovary-A 3 3 4 5 gtf2a1l///ston1 general transcription factor IIA, 1-like
Str.32359.1.A1_at NP_003869.1 Ovary-A 1 2 5 5 (ggh) gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase) Amino acid metabolism
Str.47632.1.S1_x_at NP_001137457.1 Ovary-A 2 1 3 5 baf-l (banf1) barrier to autointegration factor 1 DNA recombination
Str.15950.1.S1_s_at NP_005660.4 Ovary-A 2 2 4 5 reep6 (reep5) receptor accessory protein 5
Str.1623.1.S1_at NP_690048.1 Ovary-A 2 3 5 5 stk35 (pdik1l) PDLIM1 interacting kinase 1 like Organization of actin stress fibers
Str.38422.2.A1_a_at NP_079356.3 Ovary-A 2 2 6 8 (asrgl1) asparaginase like 1 Cancer-related
Str.49275.1.S1_at NP_775804.2 Ovary-A 2 5 7 5 tdrd5 tudor domain containing 5 Gonadogenesis, gametogenesis, meiosis, fertility (male)
|Fold-difference|
Fold difference in expression between tissues was calculated based on raw expression values and is colored according to magnitude of difference.  Red indicates ovary-enriched, blue indicates testis-enriched, yellow indicates moderate 
difference and green indicates no difference.  Gene symbols in parenthases are human gene symbols.   
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Str.6726.1.S1_at NP_653195.2 Ovary-A 3 6 6 5 gtsf1 gametocyte specific factor 1 Germ cell development
Str.38810.1.S1_at NP_056002.2 Ovary-A 1 5 5 5 sel1l3 sel-1 suppressor of lin-12-like 3 (C. elegans) Cancer-related
Str.5073.1.S1_at NP_065392.1 Ovary-A 2 4 6 5 c20orf3 (apmap) adipocyte plasma membrane associated protein Cancer-related
Str.4267.1.S1_at NP_919268.1 Ovary-A 2 2 6 6 sass6 spindle assembly 6 homolog (C. elegans) DNA replication
Str.27191.2.S1_at NP_001013682.2 Ovary-A 1 2 6 8 (frrs1) ferric-chelate reductase 1
Str.1727.2.A1_at NP_001717.2 Ovary-A 1 2 7 7 brdt bromodomain, testis-specific Gonadogenesis, chromatin remodeling (male)
Str.710.2.S1_at NP_076957.3 Ovary-A 1 1 5 8 c17orf39 (gid4) GID complex subunit 4, VID24 homolog (S. cerevisiae)
Str.4536.1.S1_at NP_543026.1 Ovary-A 1 1 6 7 (stk35) serine/threonine kinase 35 Cancer-related, organization of actin stress fibers
Str.8311.1.S1_at NP_542195.1 Ovary-A 1 3 9 5 (tldc2) TBC/LysM-associated domain containing 2
Str.34311.1.S1_at NP_001008777.2 Ovary-A 1 2 9 6 fbxo47 F-box protein 47 Cancer-related
Str.30824.1.A1_s_at NP_689551.1 Ovary-A 1 4 10 7 zg16 zymogen granule protein 16 Cancer-related
Str.37576.1.S1_s_at NP_079335.2 Ovary-A 1 4 12 8 (ccdc170) coiled-coil domain containing 170 Cancer-related
Str.32445.1.S1_s_at NP_006000.2 Ovary-A 2 3 4 18 tuba4 (tuba1a) tubulin, alpha 1a Nervous system development, microtubule dynamics
Str.32445.1.S1_at NP_006000.2 Ovary-A 2 3 3 12 (tuba1a) tubulin, alpha 1a Nervous system development, microtubule dynamics
Str.7111.1.S1_at NP_877724.1 Ovary-A 1 2 5 21 npm2 nucleophosmin/nucleoplasmin 2 Morphology of ovary, morphology of oocytes, fertility
Str.19394.1.S1_at NP_001004311.2 Ovary-A 2 3 9 27 figla folliculogenesis specific basic helix-loop-helix Gonadogenesis, ovary development, meiosis of germ cells, fertility
Str.11490.1.S2_at NP_001028253.1 Ovary-A 2 2 7 14 mycl1 v-myc myelocytomatosis viral oncogene homolog 1 Cancer-related
Str.11490.1.S1_at NP_001028253.1 Ovary-A 2 2 7 14 mycl1 v-myc myelocytomatosis viral oncogene homolog 1 Cancer-related
Str.38460.2.A1_at NP_001093392.1 Ovary-A 1 1 4 13 otud4 Cancer-related
Str.27686.1.S1_at NP_001001933.1 Ovary-A 1 1 5 14 lhx8 LIM homeobox 8 Gonadogenesis, ovary development, nervous system development
Str.4078.1.S1_a_at NP_001298.3 Ovary-B 4 5 5 10 cldn7 claudin 7 Ovarian cell proliferation, quantity of steroid hormone
Str.27610.1.S1_at NP_002344.2 Ovary-B 3 4 4 8 epcam (tacstd2) tumor-associated calcium signal transducer Ovarian cell proliferation, cellular movement
Str.51982.1.A1_s_at NP_077312.2 Ovary-B 3 6 5 7 irx3 iroquois homeobox 3 Organ development, nervous system development
Str.39298.2.S1_a_at NP_000005.2 Ovary-B 2 5 5 6 (a2m) alpha-2-macroglobulin Nervous system development, cellular movement
Str.21092.1.S1_at NP_005844.4 Ovary-B 2 4 4 5 irx5 iroquois homeobox 5 Organ development, morphology, nervous system development
StrJgi.3092.1.S1_at NP_005089.2 Ovary-B 3 3 3 5 msc musculin Muscle development
Str.8649.2.S1_x_at NP_067018.2 Ovary-B 3 3 5 11 (cldn6) claudin 6 Cell proliferation, differentiation
Str.8649.2.S1_at NP_067018.2 Ovary-B 3 3 5 11 (cldn6) claudin 6 Cell proliferation, differentiation
Str.16327.1.S1_at NP_005256.2 Ovary-B 2 1 4 5 ggt1 gamma-glutamyltransferase 1 Morphology of gonad, fertility, cell proliferation
Str.13287.1.S1_at NP_056122.1 Ovary-B 2 5 5 6 fam189a1 family with sequence similarity 189, member A1
Str.5962.2.A1_at NP_060167.2 Ovary-B 2 4 5 15 esrp1 epithelial splicing regulatory protein 1 Ovarian cell proliferation, RNA splicing
Str.5962.1.S1_at NP_060167.2 Ovary-B 2 3 6 20 esrp1 epithelial splicing regulatory protein 1 Ovarian cell proliferation, RNA splicing
Str.10951.1.S1_at NP_065826.2 Ovary-B 3 3 3 12 (kiaa1324) KIAA1324
Str.34852.1.A1_at NP_077720.1 Ovary-B 5 5 11 21 nppc natriuretic peptide C Reproductive system development, cell signaling, cell proliferation
Str.41205.1.A1_at NP_000207.2 Ovary-B 6 13 9 8 kal1 Kallmann syndrome 1 sequence Guidance of axons, cell movement, gonad development
Str.34732.1.A1_at NP_000094.2 Ovary-B 7 12 8 11 cyp19a1 cytochrome P450, family 19, subfamily A, polypeptide 1 Morphology of gonad, primary sex determination
Str.8337.1.S1_at NP_002099.1 Ovary-B 5 13 12 14 hal.2 histidine ammonia-lyase Amino acid metabolism
Str.52013.1.S1_at NP_000094.2 Ovary-B 5 8 5 6 cyp19a1 cytochrome P450, family 19, subfamily A, polypeptide 1 Morphology of gonad, primary sex determination
Str.19828.1.S1_at NP_689648.2 Ovary-B 6 5 5 6 amdhd1 amidohydrolase domain containing 1
Str.28022.1.A1_at NP_001138578.1 Ovary-B 8 13 17 17 fibcd1 fibrinogen C domain containing 1
Str.24572.1.A1_s_at NP_000774.2 Ovary-B 8 22 15 27 cyp26a1 cytochrome P450, family 26, subfamily A, polypeptide 1 Organ development, morphology, metabolism
Str.12223.1.S1_at NP_000742.1 Ovary-B 7 11 13 7 chrnd cholinergic receptor, nicotinic, delta (muscle) Muscle growth
Str.15551.1.S2_at NP_002336.1 Ovary-B 6 7 6 5 lum lumican Cell proliferation, morphology, fertility
Str.15551.1.S1_at NP_002336.1 Ovary-B 7 7 7 6 lum lumican Cell proliferation, morphology, fertility
Str.28084.1.S1_at NP_004089.1 Ovary-B 5 7 9 6 emx2 empty spiracles homeobox 2 Morphology of gonad, primary sex determination
StrEns.9618.1.S1_a_at NP_872293.2 Ovary-B 4 7 6 6 olfml2a olfactomedin-like 2A Endometrial cell proliferation
Str.38277.1.A1_at NP_001121367.1 Ovary-B 5 4 5 5 chst8 carbohydrate (N-acetylgalactosamine 4-0) s Morphology of gonad, concentration of hormone
Str.13722.1.S1_at NP_000541.1 Ovary-B 3 6 8 6 tyrp1 tyrosinase-related protein 1
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StrAffx.70.1.S1_s_at NP_004813.2 Ovary-B 21 61 43 64 ntn1 netrin 1 Nervous system development, cellular movement
Str.6910.1.S1_at NP_002088.2 Ovary-C 1 1 2 85 42Sp43 (gtf3a) general transcription factor IIIA Confirmational DNA modification, transcription
Str.7712.1.S1_a_at NP_002096.1 Ovary-C 1 1 1 56 hist1h2aa (h2afx) H2A histone family, member X Gametogenesis, meiosis, DNA repair
Str.4034.1.S1_at NP_001104516.1 Ovary-C 1 2 3 71 ccna1 cyclin A1 Gametogenesis, cell cycle progression
Str.27228.1.S1_at NP_004692.1 Ovary-C 1 1 2 34 (ccnb2) cyclin B2 Cell proliferation, fecundity
Str.1760.2.S2_at NP_071370.2 Ovary-C 1 1 2 42 cdca7 cell division cycle associated 7 Regulation of cell proliferation and transcription
Str.3994.1.S1_a_at NP_114172.1 Ovary-C 1 1 1 45 ccnb1 cyclin B1 Cell cycle progression, mitosis
Str.6258.1.S1_at NP_001167607.1 Ovary-C 1 1 2 50 cfc1 (tdgf1) teratocarcinoma-derived growth factor 1 Embryonic development, mesoderm development
StrEns.9022.1.S1_s_at NP_054879.3 Ovary-C 1 1 2 36 mkrn3 (mkrn2) makorin ring finger protein 2
Str.6468.4.S1_at NP_054879.3 Ovary-C 1 1 3 101 mkrn3 (mkrn2) makorin ring finger protein 2
Str.8156.1.S1_at NP_006073.2 Ovary-C 1 1 2 63 tuba4 (tuba1b) tubulin, alpha 1b
Str.26862.1.S1_at NP_783318.1 Ovary-C 1 1 1 25 zar1 zygote arrest 1 Oocyte-specific maternal mRNA, embryogenesis
Str.32186.1.A1_at NP_009067.2 Ovary-C 1 1 1 18 (znf80) zinc finger protein 80
Str.3682.1.S1_at NP_060059.1 Ovary-C 1 1 2 28 btg4 B-cell translocation gene 4 Cell cycle progression, cell proliferation, mitosis
Str.17082.2.S1_x_at NP_003541.2 Ovary-C 1 1 2 29 (mad1l1) MAD1 mitotic arrest deficient-like 1 (yeast) Cell cycle progression, cell proliferation, transcription
Str.1617.1.S1_at NP_067009.1 Ovary-C 1 1 1 30 zp4.2 zona pellucida glycoprotein 4 Oocyte-specific, cell signaling, activation of protein kinase
Str.3.1.S1_a_at Ovary-C 1 1 1 32 nanos1 Oocyte maternal mRNA regulation of embryonic development
Str.6457.1.S1_at NP_997309.2 Ovary-C 1 1 1 31 foxi2 forkhead box I2 Oocyte maternal mRNA activator of embryonic development (Cha et al.,1 2012)
Str.20406.1.S1_at NP_001130043.1 Ovary-C 1 1 1 33 (zar1l) zygote arrest 1-like Oocyte-specific maternal mRNA, RNA regulation embryogenesis
Str.5107.1.S1_at NP_067009.1 Ovary-C 1 1 1 36 zp4 zona pellucida glycoprotein 4 Oocyte-specific, cell signaling, activation of protein kinase
Str.27898.1.S1_at NP_003398.1 Ovary-C 1 1 1 36 zfp36l2.1 (zfp36) ZFP36 ring finger protein Cell proliferation, mRNA stabilization, transcription
Str.5859.1.S1_a_at NP_001099028.1 Ovary-C 1 1 1 41 wee2 WEE1 homolog 2 (S. pombe) Cell cycle, meiosis I, prophase I
Str.754.1.S1_at NP_690851.2 Ovary-C 1 1 1 40 (prss33) protease, serine, 33
Str.1668.2.S1_at NP_061897.1 Ovary-C 1 1 1 49 (heatr5b) HEAT repeat containing 5B
Str.30111.1.S1_at NP_001122098.1 Ovary-C 1 1 1 48 (spire1) spire homolog 1 (Drosophila)
Str.3366.1.S1_at NP_005940.1 Ovary-C 1 1 1 167 (mt1f) metallothionein 1F Cell death and survival
Str.117.1.S1_at NP_009086.4 Ovary-C 1 1 1 120 (zp3) zona pellucida glycoprotein 3 (sperm receptor) Oocyte development, gametogenesis, fertility
Str.8649.1.S1_at NP_067018.2 Ovary-C 1 1 2 91 cldn6.1 claudin 6 Cell proliferation, differentiation
Str.21536.1.S1_at NP_008818.3 Ovary-C 1 1 1 495 zfp36l2.2 ZFP36 ring finger protein-like 2 Cell proliferation, mRNA stabilization, transcription
Str.3467.1.S1_at NP_006797.3 Ovary-C 1 1 1 250 (btg3) BTG family, member 3 Cell cycle progression, cell proliferation, transcription
Str.52147.2.S1_x_at NP_001514.2 Ovary-C 1 1 1 15 (has1) hyaluronan synthase 1 Cell proliferation, cellular movement
StrEns.4910.1.S1_at NP_002051.2 Ovary-C 1 1 1 14 (gja4) gap junction protein, alpha 4, 37kDa Reproductive system development, gametogenesis, fertility
Str.3569.1.S1_at NP_001154945.1 Ovary-C 1 1 1 14 aldh3b1 aldehyde dehydrogenase 3 family, member B1
Str.6507.1.S1_at NP_722575.1 Ovary-C 1 1 1 12 h1foo H1 histone family, member O, oocyte-specific Oocyte-specific maternal mRNA
Str.17082.1.S1_s_at NP_000214.1 Ovary-C 1 1 1 11 xk81a1 (krt12) keratin 12 Disruption of keratin filaments
Str.27268.1.S1_at NP_003097.1 Ovary-C 1 1 1 12 sox3 (sox2) SRY (sex determining region Y)-box 2 Reproductive system development, cell proliferation
Str.39270.1.A1_at NP_005439.2 Ovary-C 1 1 1 13 (bmp15) bone morphogenetic protein 15 Reproductive system development, gametogenesis, fertility
Str.31989.1.A1_at NP_001002259.1 Ovary-C 1 1 2 9 caprin2 caprin family member 2 Cell proliferation, transcription
Str.10367.1.S1_at NP_001135877.1 Ovary-C 1 1 2 17 slmo1 slowmo homolog 1 (Drosophila)
Str.51662.1.A1_at NP_001159766.1 Ovary-C 1 1 2 22 (ssx2ip) synovial sarcoma, X breakpoint 2 interacting protein Cell proliferation
Str.7206.1.S1_at NP_001949.1 Ovary-C 1 1 1 18 42Sp50 (eef1a2) eukaryotic translation elongation factor 1 alpha 2 Oocyte vegetal mRNA transport (Loeber et al. 2010)
Str.1153.1.S1_at NP_001167022.1 Ovary-C 1 1 1 11 tmprss4 transmembrane protease, serine 4
Str.27710.1.S1_at NP_073587.1 Ovary-C 1 1 1 8 parp12 poly (ADP-ribose) polymerase family, member 12
Str.10709.1.S1_at NP_001073935.1 Ovary-C 1 1 1 7 btbd17 BTB (POZ) domain containing 17
StrEns.9654.1.S1_s_at NP_001002259.1 Ovary-C 1 1 1 7 caprin2 caprin family member 2 Cell proliferation, transcription
Str.15673.1.S1_at NP_009294.1 Ovary-C 1 1 1 9 comt.2 (comt) catechol-O-methyltransferase Reproductive system development, metabolism, regulation of neurotransmitter
StrJgi.8914.1.S1_s_at NP_543154.1 Ovary-C 1 1 1 7 (itln2) intelectin 2
Str.5899.1.S1_at NP_653194.1 Ovary-C 1 1 1 8 rhebl1 Ras homolog enriched in brain like 1 Regulation of cell growth and proliferation
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Str.9274.1.S1_at NP_001035189.1 Ovary-C 1 1 1 9 sptssb serine palmitoyltransferase, small subunit B
Str.51964.1.S1_s_at NP_001004343.1 Ovary-C 1 1 1 6 map1lc3c microtubule-associated protein 1 light chain 3 gamma
Str.24662.1.S1_a_at NP_009060.2 Ovary-C 1 1 1 6 zic2 Zic family member 2 Nervous system development
Str.2712.1.S1_at NP_203125.1 Ovary-C 1 1 1 7 (casp7) caspase 7, apoptosis-related cysteine peptidase Cell death and survival, tissue morphology
Str.51683.1.S1_at NP_057480.2 Ovary-C 1 1 1 6 (ctdspl2)
CTD (carboxy-terminal domain, RNA pol. II, polypep. A) small phosphatase like 
2 Phosphatase activity
Str.22168.2.S1_at NP_057405.1 Ovary-C 1 1 1 6 (rhcg) Rh family, C glycoprotein Morphology of gonad, molecular transport
Str.15798.1.S1_at NP_001123886.1 Ovary-C 1 1 1 6 (apba2) amyloid beta (A4) precursor protein-binding, family A, member 2 Exocytosis of vesicles
Str.19585.1.S1_at NP_005906.2 Ovary-C 1 1 1 5 mcm6 minichromosome maintenance complex component 6 Confirmational DNA modification
Str.4026.1.S1_a_at NP_003914.1 Ovary-C 1 1 1 5 foxh1 forkhead box H1 Embryonic development, patterning
Str.29857.1.A1_at NP_689929.2 Ovary-C 1 1 1 5 patl2 (patl1) protein associated with topoisomerase II homolog 1 (yeast)
Str.49374.1.A1_at NP_000843.1 Ovary-C 1 1 1 5 (gstp1) glutathione S-transferase pi 1 Cell proliferation, conversion of beta-estradiol
Str.33548.1.S1_at NP_001852.1 Ovary-C 1 1 1 6 (cox4i1) cytochrome c oxidase subunit IV isoform 1 Cell cycle progression
Str.46745.1.A1_s_at NP_005389.1 Ovary-C 1 1 2 7 ppp1r3c.2 protein phosphatase 1, regulatory subunit 3C Insulin regulation, glycogen homeostasis
Str.27229.1.S1_at NP_005389.1 Ovary-C 1 1 2 7 ppp1r3c.2 protein phosphatase 1, regulatory subunit 3C Insulin regulation, glycogen homeostasis
Str.9274.1.S2_at NP_001035189.1 Ovary-C 1 1 2 7 sptssb serine palmitoyltransferase, small subunit B
Str.8371.1.S1_a_at NP_001130043.1 Ovary-C 1 1 1 6 (zar1l) zygote arrest 1-like Oocyte-specific maternal mRNA, RNA regulation embryogenesis
Str.15996.2.S1_at NP_056530.2 Ovary-C 1 1 1 8 proca1 protein interacting with cyclin A2 Lipid metabolism
StrEns.5801.1.S1_s_at NP_056530.2 Ovary-C 1 1 1 7 proca1 protein interacting with cyclin A1 Lipid metabolism
Str.37482.1.S1_at NP_065109.1 Ovary-C 1 1 1 8 pnpla3 patatin-like phospholipase domain containing 2 Lipid metabolism
Str.6496.1.S1_at NP_065169.1 Ovary-C 2 1 2 9 sall4 sal-like 4 (Drosophila) Cell proliferation, growth
Str.5899.1.S2_at NP_653194.1 Ovary-C 1 1 2 8 rhebl1 Ras homolog enriched in brain like 1 Regulation of cell growth and proliferation
Str.7388.1.S1_at NP_001959.1 Ovary-C 1 1 2 15 eif4e eukaryotic translation initiation factor 4E Cell proliferation, cell death and survival, RNA trafficking
StrEns.410.1.S1_at NP_542449.1 Ovary-C 1 2 3 12 vegt T-box protein VegT Oogenesis, germ layer specification of embryo
Str.4776.1.S1_at NP_079206.2 Ovary-C 1 2 3 8 elovl7 ELOVL fatty acid elongase 7 Cell proliferation, synthesis of hormone
Str.27817.1.S1_at NP_060179.2 Ovary-C 1 2 2 5 fam46c family with sequence similarity 46, member C
Str.8000.1.S1_a_at NP_004692.1 Ovary-C 3 3 2 6 ccnb2 cyclin B2 Cell proliferation, fecundity
Str.11491.1.A1_at NP_060546.2 Ovary-C 2 4 3 7 armc4 armadillo repeat containing 4
Str.28193.1.A1_at NP_000266.2 Ovary-C 2 2 4 8 (oca2) oculocutaneous albinism II Reproductive system development, gametogenesis
Str.5962.1.S2_at NP_060167.2 Ovary-C 1 2 3 8 esrp1 epithelial splicing regulatory protein 1
Str.287.1.S1_at NP_002297.2 Ovary-C 2 2 3 5 lgals3 lectin, galactoside-binding, soluble, 3 Cell proliferation, expansion of mesangium
Str.15225.1.S1_at NP_001091089.1 Ovary-C 2 2 2 6 tmem184a transmembrane protein 184A Protein localization
StrAffx.141.1.S1_at NP_001005340.1 Ovary-C 1 1 3 10 gpnmb glycoprotein (transmembrane) nmb Cell proliferation
Str.31340.2.S1_at NP_859062.1 Ovary-C 1 1 2 5 grasp GRP1 (general receptor for phosphoinositides 1)-assoc. scaffold prot. Cell proliferation, localization, sprouting of mossy fibers
Str.31947.1.A1_at NP_001137501.1 Ovary-C 1 1 2 5 cntd2 cyclin N-terminal domain containing 2
Str.13533.1.A1_at NP_000736.2 Ovary-C 1 1 3 6 chrna5 cholinergic receptor, nicotinic, alpha 5 (neuronal) Cell signaling, nervous system development
Str.1304.1.S1_at NP_001129688.1 Ovary-C 2 1 3 6 tmem51 transmembrane protein 51
Str.116.1.S1_at NP_067009.1 Ovary-C 1 1 2 6 zpax (zp4) zona pellucida glycoprotein 4 Cell proliferation, cell signaling, activation of protein kinase
Str.33670.1.S1_at NP_001798.2 Ovary-C 1 1 1 6 (cel) carboxyl ester lipase Lipid metabolism
Str.19439.1.S1_at NP_775761.4 Ovary-C 1 1 5 13 tmem171 transmembrane protein 171
Str.31112.1.A1_at NP_877435.2 Ovary-C 1 1 6 8 wdr72 WD repeat domain 72 Cell death and survival
Str.27291.1.S1_at NP_005718.2 Ovary-C 1 1 4 16 tspan1 tetraspanin 1
Str.9495.1.S1_at NP_005846.1 Ovary-C 1 1 4 6 ramp1 receptor (G protein-coupled) activity modifying protein 1
Str.48992.1.A1_at NP_002395.1 Ovary-C 1 1 5 12 (mfap4) microfibrillar-associated protein 4
Str.6678.1.S2_at NP_008883.2 Ovary-C 1 1 1 5 upk1b uroplakin 1B
Str.20226.1.S1_at NP_055135.1 Ovary-C 1 1 1 5 hebp2 heme binding protein 2
Str.10989.1.S1_a_at NP_006399.1 Ovary-C 2 1 1 6 agr2 anterior gradient 2 homolog (Xenopus laevis) Cell proliferation, cellular movement
Str.3249.1.S1_s_at NP_001296.1 Ovary-C 1 1 1 9 cldn4 claudin 4 Cell proliferation, cellular movement
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Str.12245.1.S1_at NP_112191.2 Testis-A 6 3 5 10 kazald1 Kazal-type serine peptidase inhibitor domain 1
Str.31614.1.S1_at NP_006761.1 Testis-A 4 3 5 7 (marco) macrophage receptor with collagenous structure Cellular organization of cytoskeleton, microtubule dynamics
Str.29149.1.A1_at NP_074035.1 Testis-A 3 3 5 6 (myh11) myosin, heavy chain 11, smooth muscle Vascular development, muscle contraction
Str.31855.1.S1_at NP_001129944.1 Testis-A 10 12 16 9 (litaf) lipopolysaccharide-induced TNF factor Cellular movement
Str.37641.1.S1_at NP_004973.1 Testis-A 3 3 4 5 kcnj8 potassium inwardly-rectifying channel, subfamily J, member 8 Vascular development
Str.6049.1.A1_at NP_004604.2 Testis-A 2 2 3 6 tgm2 transglutaminase 2 (C polypeptide, protein Vasculogenesis, angiogenesis, concentration of hormone
Str.31333.1.S1_a_at NP_612379.2 Testis-A 3 3 3 6 pkdcc.2 protein kinase domain containing, cytoplasmic Connective tissue development
Str.28107.1.S1_at NP_003059.1 Testis-A 3 4 4 6 snai1 (snai2) snail homolog 2 (Drosophila) Gonadogenesis, morphology of testis, cell movement
Str.26739.1.S1_at NP_612454.1 Testis-A 2 2 3 5 gpr146 G protein-coupled receptor 146
Str.22594.1.A1_at NP_116121.2 Testis-A 2 3 4 7 (il17rc) interleukin 17 receptor C
Str.44816.1.A1_at NP_000466.2 Testis-A 4 6 9 6 (nr0b1/dax-1) nuclear receptor subfamily 0, group B, member 1 Gonadogenesis, morphology of testis, sex determination, fertility
Str.31923.1.S1_at NP_001841.2 Testis-A 3 5 6 9 (col8a1) collagen, type VIII, alpha 1 Vasculogenesis, angiogenesis
Str.37100.1.A1_at NP_699174.1 Testis-A 4 3 4 8 (enpp6) ectonucleotide pyrophosphatase/phosphodiesterase 6 Hydrolysis
Str.15452.1.S1_at NP_004627.1 Testis-A 4 4 3 5 sema3b sema domain (semaphorin), immunoglobulin domain (Ig) 3B Vasculogenesis, cellular movement, cell signalling
Str.15379.1.S1_at NP_004456.1 Testis-A 3 4 5 5 fgf10 fibroblast growth factor 10 Gonadogenesis, morphology of testis
StrJgi.3117.1.S1_s_at NP_848600.2 Testis-A 5 5 5 5 tmem26 transmembrane protein 26
Str.15388.1.A2_at NP_004568.2 Testis-A 8 4 4 5 psph phosphoserine phosphatase
Str.6594.1.S1_at NP_001035181.1 Testis-A 11 6 7 6 enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 Vasculogenesis, cellular movement
Str.52251.1.S1_at NP_003730.4 Testis-A 10 6 5 10 akr1c2 (akr1c3) aldo-keto reductase family 1, member C3 Steroid synthesis and metabolism
Str.31895.1.S1_at NP_542988.3 Testis-A 1 3 4 5 (col13a1) collagen, type XIII, alpha 1 Vasculogenesis, angiogenesis
Str.15223.6.S1_at NP_001003760.2 Testis-A 2 3 4 5 klhl31 kelch-like family member 31
Str.33336.1.A1_at NP_000410.2 Testis-A 1 3 3 5 itga2b.1 integrin, alpha 2b Morphology of vascular system, cellular movement
Str.24395.1.A1_at NP_063938.1 Testis-A 1 2 4 7 cyp26b1 cytochrome P450, family 26, subfamily B, polypeptide 1 Gonadogenesis, morphology of testis
Str.10824.1.S1_at NP_000890.1 Testis-A 2 3 5 8 kitlg KIT ligand Gonadogenesis, development of testis, steroid synthesis
Str.25601.1.A1_at NP_000798.2 Testis-A 3 3 6 9 (gabra2) gamma-aminobutyric acid (GABA) A receptor, alpha 2
Str.5581.1.S1_at NP_068733.1 Testis-A 3 3 4 6 cfl2 cofilin 2 (muscle)
Str.15616.1.S1_at NP_002914.1 Testis-A 3 4 6 7 rgs2 regulator of G-protein signaling 2, 24kDa Vascular development, development of muscle
Str.32447.1.S1_at NP_963849.1 Testis-A 3 5 6 8 fhl5 (fhl2) four and a half LIM domains 2 Angiogenesis, cellular movement, muscle cell development
Str.5047.1.S2_at NP_001918.3 Testis-A 2 3 4 6 des.1 desmin Morphology of vascular system
Str.28002.1.S1_at NP_001071642.1 Testis-A 1 3 5 7 (slc29a1) solute carrier family 29 (nucleoside transporters), member 1 Cellular proliferation
Str.22906.1.S1_at NP_511040.2 Testis-A 1 2 2 5 col9a1 collagen, type IX, alpha 1 Connective tissue development
Str.5759.1.S1_at NP_001303.1 Testis-A 1 1 2 7 crip2 cysteine-rich protein 2 Cellular proliferation, cellular differentiation
Str.1843.2.S1_at NP_005621.2 Testis-A 1 1 3 6 slco2a1 solute carrier organic anion transporter family, member 2A1 Morphology of vascular system, molecular transport
Str.38324.1.S1_at NP_057315.3 Testis-A 1 2 2 5 nlk nemo-like kinase Morphology of vascular system
Str.17054.1.S1_at NP_001437.1 Testis-A 1 2 4 24 fabp7 fatty acid binding protein 7, brain Cellular proliferation, cellular movement
Str.27613.3.S1_at NP_005323.1 Testis-A 3 2 2 8 hba-l2 (hbz) hemoglobin, zeta Morphology of vascular system
Str.12190.1.S1_at NP_003751.2 Testis-A 2 8 11 17 fstl5 (eif4g3) eukaryotic translation initiation factor 4 gamma, 3 Cellular organization of cytoskeleton, microtubule dynamics
Str.39178.2.A1_at NP_001452.2 Testis-A 5 7 10 15 fmo5 flavin containing monooxygenase 5
Str.39178.1.S1_a_at NP_001452.2 Testis-A 5 6 8 14 fmo5 flavin containing monooxygenase 5
Str.13088.1.S1_at NP_004725.1 Testis-A 5 6 7 14 dclk2 (dclk1) doublecortin-like kinase 1 Cellular organization of cytoskeleton, microtubule dynamics
Str.25076.1.A1_at NP_004168.1 Testis-A 5 8 10 8 (stx3) syntaxin 3 Cellular organization of cytoskeleton, microtubule dynamics
Str.21675.1.A1_at NP_000521.2 Testis-A 6 5 9 11 mpz myelin protein zero Nervous system development, cellular movement
Str.39202.1.S1_at NP_006320.2 Testis-A 6 7 8 17 fbln5 fibulin 5 Vascular development, cellular movement
Str.26721.1.S1_at NP_002183.1 Testis-A 2 2 4 10 inhba inhibin, beta A Morphology of testis, fertility, steroidogenesis, cellular movement
Str.24498.1.S1_at NP_001161146.1 Testis-A 2 2 3 6 cadm2 cell adhesion molecule
Str.15475.1.S1_at NP_689917.2 Testis-A 3 4 5 7 fam123a (amer2) APC membrane recruitment protein 2
Str.21927.1.S1_at NP_056965.3 Testis-A 4 3 5 10 dkk3 dickkopf 3 homolog (Xenopus laevis) Steroid hormone synthesis, cellular movement, cellular organization
Str.38097.1.A1_at NP_066382.1 Testis-A 3 4 4 6 (dhh) desert hedgehog Gonadogenesis, morphology of testis, sex determination, steroid synthesis
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Str.51661.1.S1_at NP_001329.1 Testis-A 2 3 4 8 cxadr coxsackie virus and adenovirus receptor Vascular development, cellular movement
Str.8537.1.S1_at NP_001290.2 Testis-A 3 6 6 9 cnn2 (cnn1) calponin 1, basic, smo Vascular development, cellular movement, morphology of testis
Str.51373.1.A1_at NP_001137417.1 Testis-A 3 5 7 7 (gas6) growth arrest-specific 6 Vascular development, cellular movement
Str.39201.1.S1_at NP_002182.1 Testis-A 3 3 3 6 inha inhibin, alpha Morphology of testis, fertility, steroidogenesis, sex determination
Str.37326.1.A1_x_at NP_006158.2 Testis-A 4 10 12 14 (nkx3-1) NK3 homeobox 1 Morphogenesis of testis
Str.17189.1.S1_at NP_000339.2 Testis-A 5 8 11 16 srd5a2 steroid-5-alpha-reductase, alpha polypeptide 2 Steroidogenesis, fertility, sex determination, morphology of testis
StrJgi.3167.1.S1_x_at NP_006158.3 Testis-A 6 12 16 16 (nkx3-1) NK3 homeobox 1 Morphogenesis of testis
Str.37326.1.A1_s_at NP_006158.2 Testis-A 6 12 15 15 (nkx3-1) NK3 homeobox 1 Morphogenesis of testis
Str.5526.1.S1_at NP_003280.2 Testis-A 6 10 12 22 tpm2 tropomyosin 2 (beta) Vascular development, muscle contraction
Str.8998.1.S1_at NP_001034933.1 Testis-A 15 23 10 8 acbd7 acyl-CoA binding domain containing 7
Str.38286.1.A1_at NP_002227.2 Testis-A 8 7 7 7 kcnf1 potassium voltage-gated channel, subfamily F, member 1
Str.7705.5.S1_at NP_001135934.1 Testis-A 7 9 13 11 osr2 odd-skipped related 2 (Drosophila) Cellular proliferation, growth
Str.38466.1.S1_at NP_000093.1 Testis-A 11 8 9 11 cyp17a1 cytochrome P450, family 17, subfamily A, polypeptide 1 Steroidogenesis, fertility, sex determination
Str.11952.1.S1_at NP_001120645.1 Testis-A 10 7 9 10 (cadm3) cell adhesion molecule 3
Str.21742.1.S1_at NP_001109.2 Testis-A 8 6 8 6 adcyap1r1 adenylate cyclase activating polypeptide 1 (pituitary) receptor type I Cellular proliferation, concentration of hormone, fertility
Str.52145.1.S1_at NP_003730.4 Testis-A 6 6 7 8 akr1cl1 (akr1c3) aldo-keto reductase family 1, member C3 Steroidogenesis
StrJgi.5073.1.S1_s_at NP_003730.4 Testis-A 6 6 6 7 akr1cl1 (akr1c3) aldo-keto reductase family 1, member C3 Steroidogenesis
Str.19735.1.S1_at NP_003586.3 Testis-A 6 5 7 7 tpst2 tyrosylprotein sulfotransferase 2 Cellular movement, fertility
Str.11990.1.S1_at NP_996846.1 Testis-A 13 9 10 11 rarres1 retinoic acid receptor responder (tazarotene induced) 1 Cellular movement
Str.5014.1.S1_at NP_001135417.1 Testis-B 9 12 12 23 acta2 actin, alpha 2, smooth muscle, aorta Vascular development, muscle contraction
Str.21784.1.A1_s_at NP_002072.2 Testis-B 13 11 17 22 gpc1 glypican 1 Vascular development, cellular movement
Str.21784.1.A2_at NP_002072.2 Testis-B 12 12 16 19 gpc1 glypican 1 Vascular development, cellular movement
Str.20614.1.S1_at NP_932766.1 Testis-B 17 5 12 19 aqp1 aquaporin 1 (Colton blood group) Vascular development, permeability of blood vessel, molecular transport
Str.22031.1.S1_at NP_001877.1 Testis-B 22 18 21 21 cryba4 crystallin, beta A4
Str.38708.1.A1_at NP_001138378.1 Testis-B 19 14 12 20 (clec4m) C-type lectin domain family 4, member M Cell-to-cell signaling and interaction
Str.28004.1.A1_at NP_000859.1 Testis-B 16 24 25 36 (htr2c) 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled Cell-to-cell signaling and interaction
Str.16705.1.A1_at NP_570844.1 Testis-B 26 30 41 65 (opa1) optic atrophy 1 (autosomal dominant) Mitochondrial organization, synthesis of pregnenolone
Str.33400.1.S1_at NP_005723.2 Testis-B 22 25 21 21 (rad50) RAD50 homolog (S. cerevisiae) Cell death of embryonic stem cells, DNA repair
Str.28021.1.A1_at NP_775101.1 Testis-B 17 17 22 19 slitrk4 SLIT and NTRK-like family, member 4 Formation of cellular protrusions, nervous system development
Str.21273.1.A1_at NP_002513.2 Testis-B 70 36 53 47 nptx1 neuronal pentraxin I Angiogenesis, cellular movement, nervous system development
Str.7898.1.S1_at NP_002467.1 Testis-B 17 88 97 98 myl4 myosin, light chain 4, alkali; atrial, embryonic Vascular development, muscle contraction
Str.38523.1.S1_at NP_001002036.3 Testis-B 26 59 68 186 (astl) astacin-like metallo-endopeptidase (M12 family) Protein synthesis, fertility
Str.12662.1.S1_at NP_689642.3 Testis-B 37 98 110 151 fgfbp3 fibroblast growth factor binding protein 3 Growth factor regulation, angiogenesis
Str.2374.2.A1_at NP_001190.1 Testis-B 19 38 107 930 (bmp1) bone morphogenetic protein 1 Collagen development, protein synthesis 
Str.34508.1.S1_s_at NP_001190.1 Testis-B 8 12 27 161 (bmp1) bone morphogenetic protein 1 Collagen development, protein synthesis 
Str.24477.2.S1_at NM_001265587.1 Testis-B 222 302 314 289 rflcii (insl3) insulin-like 3 (Leydig cell) Testis development, fertility
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